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Executive Summary 
Background 
This Commission addresses several priority areas for psychiatry over the next decade, and into the 
21st century. These represent challenges and opportunities for the profession to sustain and 
develop itself to secure the best possible future for the millions of people worldwide who will face 
life with mental illness. 
Part 1: The patient and treatment 
Who will psychiatrists help? The patient population of the future will reflect general demographic 
shifts towards older, more urban, and migrant populations. While technical advances such as the 
development of biomarkers will potentially alter diagnosis and treatment, and digital tech-nology 
will facilitate assessment of remote populations, the human elements of practice such as cultural 
sensitivity and the ability to form a strong therapeutic alliance with the patient will remain central. 
Part 2: Psychiatry and health-care systems 
Delivering mental health services to those who need them will require reform of the traditional 
structure of services. Few existing models have evidence of clinical effectiveness and acceptability to 
service users. Services of the future should consider stepped care, increased use of multidisciplinary 
teamwork, more of a public health approach, and the integration of mental and physical health care. 
These services will need to fit into the cultural and economic framework of a diverse range of 
settings in high-income, low-income, and middle-income countries. 
Part 3: Psychiatry and society 
Increased emphasis on social interventions and engagement with societal expectations might be an 
important aƌea foƌ psǇĐhiatƌǇ͛s deǀelopŵeŶt. This Đould eŶĐoŵpass adǀoĐaĐǇ foƌ the ƌights of 
individuals living with mental illnesses, political involvement concerning the social risk factors for 
mental illness, and, on a smaller scale, work with families and local social networks and 
communities. Psychiatrists should therefore possess communication skills and knowledge of the 
social sciences as well as the basic biological sciences. 
Part 4: The future of mental health law 
Mental health law worldwide tends to be based on concerns about risk rather than the protection of 
the rights of individuals experiencing mental illness. The United Nations Convention on the Rights of 
Persons with Disabilities, which states that compulsion based in whole or in part on mental disability 
is discriminatory, is a landmark document that should inform the future formulation and reform of 
mental health laws. An evidence-based approach needs to be taken: mental health legislation should 
mandate mental health training for all health professionals; ensure access to good-quality care; and 
cover wider societal issues, particularly access to housing, resources, and employment. All 
governments should include a mental health impact assessment when drafting relevant legislation. 
Part 5: Digital psychiatry—enhancing the future of mental health 
Digital technology might offer psychiatry the potential for radical change in terms of service delivery 
and the development of new treatments. However, it also carries the risk of commercialised, 
unproven treatments entering the medical marketplace with detrimental effect. Novel research 
methods, transparency standards, clinical evidence, and care delivery models must be created in 
collaboration with a wide range of stakeholders. Psychiatrists need to remain up to date and 
educated in the evolving digital world. 
Part 6: Training the psychiatrist of the future 
Rapid scientific advance and evolving models of health-care delivery have broad implications for 
future psychiatry training. The psychiatrist of the future must not only be armed with the latest 
medical knowledge and clinical skills but also be prepared to adapt to a changing landscape. Training 
programmes in an age in which knowledge of facts is less important than how new knowledge is 
accessed and deployed must refocus from the simple delivery of information towards acquisition of 
skills in lifelong learning and quality improvement. 
Conclusion 
Psychiatry faces major challenges. The therapeutic relationship remains paramount, and 
psychiatrists will need to acquire the necessary communication skills and cultural awareness to work 
optimally as patient demographics change. Psychiatrists must work with key stakeholders, including 
policy makers and patients, to help to plan and deliver the best services possible. The contract 
between psychiatry and society needs to be reviewed and renegotiated on a regular basis. Mental 
health law should be reformed on the basis of evidence and the rights of the individual. Psychiatry 
should embrace the possibilities offered by digital technology, and take an active role in ensuring 
research and care delivery in this area is ethically sound and evidence based. Psychiatry training 
must reflect these multiple pressures and demands by focusing on lifelong learning rather than 
simply knowledge delivery. 
Introduction 
Psychiatry has always been a medical discipline, but was this development inevitable, and will it 
always be this way? The profession has changed so much since so-called alienists treated their 
alienated patients up to the 19th century, when psychiatry as a term emerged. Changes in diagnostic 
practices, investigations, and therapeutic interventions—pharmacological, psycho-logical, and 
social—have brought psychiatric practice out of asylums and into the community in many countries, 
but not universally. Early intervention has gone from being an intriguing innovation to standard 
practice in many countries. However, delivery of these services depends upon resources available, 
and in many countries around the world such services remain aspirations. 
Psychiatry in the first quarter of the 21st century is at the cusp of major changes. The scientific 
community is beginning to understand more about the structures of the brain and its development 
and function—and, more importantly, the effects of social factors on these processes. Recent 
investigations into the interactions between the immune system and the brain and into optogenetics 
promise new knowledge of mechanisms and new treatments. Psychopharmacogenomics can enable 
clinicians and researchers to profile the pharmacodynamics and pharmacokinetics of individuals to 
develop and deliver more targeted interventions. 
The world is becoming more connected, and psychiatry is no exception to this phenomenon. On the 
one hand, the rise of the global mental health movement has highlighted the importance of mental 
health; on the other hand, this movement is often perceived to be yet another example of the 
so-called western Anglo-centric countries dictating to the rest of the world what needs to be done, 
ignoring different cultural models of expressing distress and seeking help. The global mental health 
movement needs to put much more emphasis on sharing examples of good clinical practice than it 
has done so far, because globalisation and urbanisation present not only challenges but also an 
opportunity to share knowledge. Furthermore, this interconnectedness both fuels and is enhanced 
by the growth of digital technology, whose effect on mental health is uncertain, and whose impact 
on the delivery of treatment might be immense. It is time to look at where psychiatry has been, 
where it is now, and to try to imagine its future. What will psychiatrists do, how will they do it, and 
what will they need to know in the next few decades? Who will psychiatrists treat? How will this 
tƌeatŵeŶt ďe deliǀeƌed aŶd fiŶaŶĐed? Hoǁ ǁill psǇĐhiatƌǇ͛s ƌelatioŶship ǁith soĐietǇ ĐhaŶge? Hoǁ 
should mental health laws adapt to accommodate this? Will psychiatry be able to go digital, and if 
so, how? And how will psychiatrists of the future be trained? 
To answer these questions, the World Psychiatric Association and The Lancet Psychiatry have 
commissioned a team of mental health professionals, researchers, and service users to write and 
review this new Commission on the future of psychiatry. The following pages are intended to 
stimulate thought, debate, and the change necessary for psychiatry to fulfil its potential as an 
innovative, effective, and inclusive medical specialty in the 21st century. 
Part 1: The patient and treatment 
Introduction 
The dramatic neuroscience research advances in psychiatry of the second half of the 20th century 
have not yet led to substantial advances in patient care. In spite of this, patient care has been 
transformed by a number of other influences. The increasing recognition of social determinants of 
health has clearly led to increased appreciation of demographic, economic, and sociocultural aspects 
of risk for development of psychiatric disorders, patient acceptance of treatment, and design and 
implementation of systems of care. Furthermore, although diagnostic systems have continued to be 
refined, all those in use across the globe are at present non-aetiological approaches, awaiting the 
development of improved understanding of the complex factors in the aetiology of psychiatric 
disorders. Treatment decisions therefore rest on the resources available to the patient in a particular 
setting, and on the best evidence based on clinical experience combined with the emerging clinical 
outcomes from research findings. In this section of the Commission, we review a number of areas of 
particular concern in the present patient assessment and care arena. 
Demographic and societal factors affecting the patient  
The future of the psychiatric patient in the health-care system will be influenced by many factors, 
several of which will be discussed in other sections of this report. One of the most critically 
important variables is the availability of and access to psychiatric care. WHO data1 show vast 
discrepancies in resources across countries, with, for example, nearly 100-times variations in the 
per-capita availability of psychiatrists.2 Within specific countries, substantial geographical variations 
occur in the availability of mental health clinicians and facilities as well as in specific treatment 
modalities such as pharma cological, psycho therapeutic, or psycho-social interventions, or neuro 
modulation therapies. 
In the USA, which has over 50 000 psychiatrists—one of the highest per-capita ratios in the world—
and an extensive array of government and privately supported programmes, many subpopulations 
have inadequate access to any aspects of clinical mental health care including medications. Owing to 
substantial fragmentation compared with the general health system, access is constrained for those 
living in rural areas and poverty-stricken urban cores, and elderly people, children, the homeless, 
victims of abuse, those in forensic facilities, and members of minority racial and ethnic groups.3 
Thus, it is uncertain whether many of our projected changes to patient care will be available to the 
majority of the global population in the next 10 years. 
Although no evidence shows that the epidemiology of most psychiatric disorders is changing, 
large-scale demographic and societal changes already underway will affect individual and population 
mental health. Four such changes, already occurring in Asia and major population centres elsewhere, 
can illustrate this. 
First, ageing of the global population will continue due to improved nutrition and water supplies as 
well as advances in general medical care.4 The growth in the elderly population means an increase in 
age-related diseases such as the dementias and late-life depression. Changes in social patterns, with 
multiple generations of families no longer living in the same houses or even the same towns, will 
alter the role of elderly people in the community and the way they are valued and cared for. The 
increased demands for caregiving by younger family members for the older generations will be less 
likely to be served when those younger generations live far away. These changes impair the quality 
of life of elderly people and can lead to poor mental health outcomes.5 Moreover, the high 
prevalence of coexisting physical conditions, such as sensory loss, will exert a greater effect on 
mental health through the loss of self-esteem and independence. 
“eĐoŶd, aŶ iŶĐƌeasiŶg peƌĐeŶtage of the ǁoƌld͛s populatioŶ ǁill ďe liǀiŶg iŶ uƌďaŶ aƌeas. 
Urbanisation affects mental health through the influence of increased stressors and factors such as 
an overcrowded and polluted environment, high levels of violence, access to illicit drugs, and 
reduced social support.6 For example, low-paid urban workers often live in crowded spaces with 
poor basic sanitation, food supplies, and shelter, as well as few—if any—basic governmental and 
social support services. 
Third, population disruption and migration due to natural and manmade disasters are at the highest 
level in recorded history,7 with associated adverse effects on mental health.8 The stresses of forced 
emigration—physical, social, and psychological—have taxed all societal systems.9 These stresses 
stem not only from factors directly related to migration or living in refugee camps, but also from 
living under the authority of individuals with, most often, a different culture, language, and 
traditions. 
Fourth, the rapidly expanding use of electronic communications in the digital world has led to 
concerns about the effect of more constant digital connectivity on individuals, such as a reduced 
attention span and changes to interpersonal relationships and society (see Part 5: Digital psychiatry). 
For example, internet addiction disorder, although not listed in DSM-5, is of increasing concern in 
adolescents and young adults. In addition, a strong association exists between internet addiction 
disorder and depression10 although the causal relationship has not been determined. 
Culture and patient care 
Culture and diagnosis 
With the vast migration of populations in recent decades, the importance of cultural factors in 
understanding mental processes of both individuals and groups and in psychiatric practice will 
continue to grow. Diagnosis will continue to be among the most complex issues in psychiatry and 
will have to take increasing notice of the influence of culture.11 Cultural variations must be taken 
iŶto aĐĐouŶt iŶ the ĐliŶiĐiaŶ͛s uŶdeƌstaŶdiŶg of the ĐoŶteǆt aŶd ŵeaŶiŶg of the laŶguage of patieŶts, 
and this appreciation must be a basic component of every diagnostic interpretation. To understand 
what patients are communicating requires the clinician to have an awareness of the effect cultural 
relativism has on language and on other variables, and such awareness will produce more effective 
decision making about normality and psychopathology.12 
The migration of human populations has modified local and regional cultures, but culture continues 
to be influenced by a multiplicity of factors, and global cultural diversity will persist. Assessment of 
race and ethnicity, language (verbal and non-verbal), religious beliefs, traditions, values and moral 
thought, family and gender issues, social relations, financial philosophies, and economic status will 
continue to be key elements for clinicians to consider when formulating a diagnosis.13 
These and other cultural variables affect areas such as help-seeking patterns, causal attributions, 
explanatory models of illness, and severity assessment. The cultural elements inserted in several 
sections of DSM-5 are only the initial step in a conceptual and practical consolidation of culture in 
the diagnostic process.14 Study of idioms of distress and cultural syndromes in various diagnostic 
schemes should continue to be refined and implemented in a way that can be used more effectively 
around the world.15 
DSM-5 developed the cultural formulation interview as a novel 16-question measurement 
instrument of cultural diagnostic components to be used during an initial interview. This process was 
field-tested for utility, and is supported by 12 supplementary modules to broaden and deepen the 
collected data.16 Thus, the cultural formulation interview can serve as a platform for further 
development. 
Culture and the therapeutic alliance 
Understood as the common and shared effort of physician and patient aimed at the alleviation, 
healing, or cure of ailments, the therapeutic alliance entails knowledge, attitudes, and skills that, if 
appropriately used, will result not only in the stated objectives but also in the prevention of relapses 
and the accomplishment of improved quality of life for the individual and the community. The 
therapeutic alliance is moderated by the knowledge base and skills of the clinician, the influence of 
culture on the system of care, and the cultural background of the physician and the patient. 
Increasing attention is paid to the role of these factors in the development and maintenance of a 
productive therapeutic alliance.11,17 
As an individual, the physician absorbs the general principles and particular features of the culture of 
medicine as practised in their location and filtered through their own cultural background. The 
patieŶt͛s Đultuƌal ďaĐkgƌouŶd ďƌiŶgs ǁith it ĐoŶĐeptioŶs of tƌust, ƌespeĐt foƌ authoƌitǇ figuƌes, 
dignity, self-image, self-esteem, and family-nourished beliefs and attitudes that the physician needs 
to appreciate to develop a positive and productive therapeutic alliance. In psychiatry, the 
therapeutic alliance is also affected by prejudice, stigma (including self-stigmatisation18), and 
discrimination, which are powerful cultural forces in most societies. 
Culture and psychiatric treatment 
Cultural competence is important not only in diagnosis and in the therapeutic alliance but also in the 
foƌŵulatioŶ aŶd eǆeĐutioŶ of a tƌeatŵeŶt plaŶ.ϭϭ The patieŶt͛s Đultuƌe ŵight iŶflueŶĐe their 
willingness to engage in the type of emotional self-disclosure that is essential for all forms of 
psǇĐhotheƌapǇ. Cultuƌal aŶd spiƌitual ďeliefs ŵight iŶflueŶĐe the patieŶt͛s peƌĐeptioŶ of aŶ iŶteƌŶal 
locus of control of their thoughts, emotions, and behaviours. Both these factors would influence, for 
example, a prescription for psychotherapy and its implementation. Thus, development and use of 
culturally sensitive psychotherapies and psychosocial interventions should be encouraged. In some 
cultures, pharmacotherapy prescriptions might be affected by traditional medicinal treatments and 
potential conflicts with traditional healers, which must receive particular attention from the 
psychiatrist.19 The cultural aspects of all components of the psychiatric care system should receive 
much more emphasis in the coming decade, with resources devoted to training, research, and 
clinical system development aimed to better equip clinicians to provide excellent culturally 
competent care.20,21 
Culture and stigma 
Culturally influenced discrimination against those with psychiatric illnesses, their families, and those 
who provide treatment for them has been known for centuries in essentially every society or culture. 
The discriminatory results of this stigmatisation have influenced media portrayals of patients with 
psychiatric disorders and their families, and of both clinicians who provide mental health care and 
the settings in which they work. In modern times, this stigmatisation has affected not only the place 
of psychiatry in the health-care system, but also governmental willingness to support adequate 
facilities, non-discriminatory policies regarding access, training of clinicians, and reimbursement for 
psychiatric care compared with all other components of the health system—even in a well 
developed health-care system such as in the USA.3 Furthermore, strong evidence suggests that 
substantial stigmatisation continues to exist among other physicians.22 
As FiŶk aŶd TasŵaŶ ǁƌote iŶ ϭϵϵϮ, ͞PatieŶts͛ ǁilliŶgŶess oƌ uŶǁilliŶgness to be treated, the inability 
to pay for treatment, and the unwillingness of people to have mentally ill persons living near them 
or working in their companies have combined to form the most powerful antitherapeutic forces that 
mentally ill individuals faĐe.͟ϭϴ Although iŵpƌessioŶistiĐ iŶfoƌŵatioŶ fƌoŵ ŵaŶǇ ĐliŶiĐiaŶs aƌouŶd 
the world suggests that stigma in the psychiatric sphere of concern has been diminishing in recent 
decades, little formal psychiatric research is devoted to this topic. Culturally influenced stigma still 
appeaƌs to haǀe aŶ adǀeƌse effeĐt oŶ patieŶts͛ ǁilliŶgŶess to seek Đaƌe.Ϯϯ IŶ ŵaŶǇ ĐouŶtƌies, 
academic institutions, psychiatric and other mental health-related organisations, and governments 
have implemented programmes to reduce stigmatisation, but these efforts are often local or 
regional in scope and influence, resulting in little study of national or cross-national assessments of 
stigma reduction. This paucity of data makes informal conclusions impossible to verify. 
The tumultuous state of the world makes it difficult to predict whether adequate resources will be 
available to foster growth of sorely needed multifocal, strategically targeted programmes in the next 
10 years. In addition, cultural change, which is necessary for widespread changes in attitudes and 
behaviour regarding mental health, comes at a very slow pace in most conditions. Both these factors 
suggest that a dramatic reduction in stigmatisation is unlikely to occur in the near future, with most 
changes likely to be gradual, modest, and geographically diverse. 
Diagnostic assessment 
Across medicine, diagnosis first involves the gathering of multiple types of information from 
different sources (eg, history, examination, and investigations), which is then considered, weighted, 
and integrated by the clinician who makes a decision on the likely diagnosis. Changes in psychiatric 
diagnostic practice could involve alterations in the way initial information is collected, the type of 
information that is gathered and used, and the way data are integrated into a diagnostic decision. 
Typically, the diagnostic act begins with the clinician gathering information reported by the patient 
or others who know them well. Across medicine, the need to listen carefully, elicit relevant 
information, empathise, and observe remains crucial for any successful diagnostic assessment. 
The psychiatric formulation is broader than diagnosis alone. It takes into account the social context, 
contributory risk and protective factors, and developmental change. These factors are relevant to 
formulation of the management plan, selection of appropriate treatments, and prediction of 
adherence and prognosis. This approach is unlikely to be replaced by a purely biological or 
investigative approach and in its ideal form should continue to be based on an integrative 
biopsychosocial-cultural formulation. 
Given the global scarcity of resources, the level of direct clinician contact with a patient is likely to 
change over the next 10 years; few, if any, places have sufficient clinicians with enough time to meet 
population demands and needs. Mobile, internet, and telemedicine technologies already enable 
remotely administered, online diagnostic interviews (eg, the Development and Well-Being 
Assessment) and cognitive testing that are used in research and in some clinical settings. Such 
approaches could enhance task shifting from physicians to health-care workers in low-income and 
middle-income countries (LMICs).24 
One of the holy grails of clinical psychiatry is laboratory tests to assist in diagnostic assessment—a 
standard component of diagnosis in most other medical specialties. Existing definitions of mental 
disorders are based exclusively on subjective signs and patient-reported symptoms that are prone to 
recall error and misinterpretation. Laboratory tests have potential advantages, including being more 
objective25 and facilitating the detection of mental disorders in primary care settings, in which the 
use of laboratory tests is routine.26 
Unfortunately, although one of the goals of DSM-5 was to make the diagnostic system more based 
on the underlying pathophysiology of mental disorders than on their symptomatic 
presentations,27,28 no laboratory tests or other biomarkers were deemed to be sufficiently 
sensitive and specific to warrant their inclusion in the DSM-5 diagnostic criteria sets for any of the 
mental disorders. 
One of the causes of the failure of studies searching for useful diagnostic biomarkers might be the 
erroneous assumption that the DSM categories represent true disease entities instead of diagnostic 
behavioural measures that cut across current disorder categories and that can inform future 
ƌeǀisioŶs of ouƌ diagŶostiĐ sǇsteŵ͟.ϯϭ 
RDoC-inspired insight into the relationship between biological processes and psychiatric symptoms 
might allow for the incorporation into psychiatry of clinically useful, diagnostically specific 
biomarkers over the next decade. To facilitate the incorporation of such measures in diagnostic 
practices, the DSM revision process is moving from one that permits updates only at fixed intervals 
to one that allows for the incorporation of empirically based changes on a continuous basis.32 
A more likely change in diagnostic assessment practices will be the increased use of measurement 
based care in routine clinical practice. Measurement based care involves the use of clinician 
administered and self report scales for disease assessment, tracking, and treatment to achieve 
optimal outcomes.33 Although measurement based care already forms the bedrock of the 
management of chronic medical conditions such as diabetes and hypertension, it is infrequently 
used for assessment and monitoring of psychiatric conditions,34 despite calls for its widespread 
adoption by psychiatric clinicians.33,35 
Primary care physicians routinely assess basic health measurements such as pulse, blood pressure, 
and weight and regularly conduct a so-called review of systems to enquire about the most common 
problems that can affect various body systems. Psychiatry would benefit from a standardised toolkit 
of psǇĐhiatƌiĐ ŵeasuƌes that ǁould ďoth pƌoǀide a piĐtuƌe of the iŶdiǀidual͛s ŵeŶtal health status 
and facilitate monitoring of specific conditions. constructs created by expert consensus.29,30 The US 
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RDoC-inspired insight into the relationship between biological processes and psychiatric symptoms 
might allow for the incorporation into psychiatry of clinically useful, diagnostically specific 
biomarkers over the next decade. To facilitate the incorporation of such measures in diagnostic 
practices, the DSM revision process is moving from one that permits updates only at fixed intervals 
to one that allows for the incorporation of empirically based changes on a continuous basis.32 
A more likely change in diagnostic assessment practices will be the increased use of measurement 
based care in routine clinical practice. Measurement based care involves the use of clinician 
administered and self report scales for disease assessment, tracking, and treatment to achieve 
optimal outcomes.33 Although measurement based care already forms the bedrock of the 
management of chronic medical conditions such as diabetes and hypertension, it is infrequently 
used for assessment and monitoring of psychiatric conditions,34 despite calls for its widespread 
adoption by psychiatric clinicians.33,35 
Primary care physicians routinely assess basic health measurements such as pulse, blood pressure, 
and weight and regularly conduct a so-called review of systems to enquire about the most common 
problems that can affect various body systems. Psychiatry would benefit from a standardised toolkit 
of psǇĐhiatƌiĐ ŵeasuƌes that ǁould ďoth pƌoǀide a piĐtuƌe of the iŶdiǀidual͛s ŵeŶtal health status 
and facilitate monitoring of specific conditions. 
 To promote the routine clinical use of psychiatric measures, the developers of DSM-5 proposed the 
addition of a dimensional component to the diagnostic categories. This dimensional component took 
two forms: cross-cutting symptom measures that would function as a psychiatric review of systems 
and disorder-specific severity measures that might be useful in making treatment decisions and 
monitoring treatment response (panel 1). 
DSM-5 field testing of the cross-cutting measures in academic settings indicated that most of the 
scales had good-to-excellent reliability37 and suggested that self-selected participants in the DSM-5 
clinical practice field trials found them useful;38 however, evidence establishing the feasibility of 
their widespread implementation in clinical practice settings was insufficient. Ultimately, this 
proposed dimensional component did not become part of the official DSM-5 diagnostic system but 
was relegated to the Emerging Measures and Models section. This decision shows the paramount 
importance of considering feasibility of implementation and user acceptability in the adoption of 
diagnostic assessment practices.39 Computerised implementation of dimensional scales, especially 
self-report measures, has the potential to substantially improve the availability and ease of use of 
dimensional measures. Improvements in technology, as well as the steadily increasing use of 
computers in clinical settings over the next decade, will facilitate their implementation in routine 
clinical practice. Increased pressure for clinicians to demonstrate quality care by measuring patient 
improvement will also incentivise their more widespread use. 
Concerns about litigation and complaints, as well as patient-generated self-diagnosis (using 
internet-based information), might also stimulate the development of more standardised 
decision-making tools. These tools might function more as an adjunct rather than a replacement for 
clinical judgment, because of the complexity of the clinical data and the situation in which the 
formulation is developed. 
Genetic information, when combined with other risk data (eg, family history and task-based 
cognitive data) might also aid estimation of the risks of future adverse outcomes—eg, development 
of Alzheiŵeƌ͛s disease.ϰϬ Futuƌe examples could include risk estimation for the conversion of 
subgroups with psychotic-like symptoms or high-risk mental states to full-blown psychotic illness, 
adolescent depression that is likely to convert to bipolar disorder, and child neurodevelopmental 
disorder subtypes that develop into schizophrenia. Identification of very high-risk subgroups 
becomes worthwhile when it alters clinical management. A clinician who knows an adolescent is at 
an elevated risk of psychosis or bipolar disorder might be more cautious about prescribing a 
stimulant medication for attention deficit hyperactivity disorder or an SSRI medication for unipolar 
depression. 
The completion of the first revision in 25 years of the Mental and Behavioural Disorders chapter of 
the ICD over the next several years will affect diagnostic assessment globally, as most countries use 
the ICD mental disorders classification.41 Proposed improvements include a more clinically useful 
scheme to lay out the classification, clinical descriptions, and diagnostic guidelines such that format 
and content are presented in a more consistent way across all diagnostic categories; a dimensional 
approach to personality disorder classification; and several new disorders, such as prolonged grief 
disorder. 
In summary, 10 years from now, diagnostic assessment based on internationally recognised 
nosological systems will probably be similar to diagnostic assessment as it is today. Clinicians will 
continue to rely on a careful personal assessment of signs and symptoms to make psychiatric 
diagnoses, although some diagnostically useful biomarkers might become available and 
in-corporated into a future interim revision of the DSM.40,42 The most likely change over the next 
decade will be more widespread use of dimensional assessments, facilitated by increasing 
penetration of computer technology into psychiatric clinical care. 
Treatment planning and implementation 
The centrality of the therapeutic alliance 
Despite anticipated advances in the diagnosis and treatment of mental disorders, none of the 
innovations to be discussed is likely to displace the centrality of the doctor–patient relationship as 
the cornerstone of clinical care. This point is vital to the definition of the field, but more importantly 
serves as part of the healing processes. The doctor–patient relationship is not a placebo but an 
essential part of all clinical care. New interventions, such as psychopharmacological and 
neuromodulation treatments, have all been provided within the context of the therapeutic 
relationship. Clinicians seem persistently forced to rediscover what research has repeatedly 
reaffirmed: quality treatment is not about compliance—it is based on alliance. 
In recent decades, the nature of the therapeutic alliance has been altered by several factors. During 
much of the 20th century, the rise of large institutions that provide a substantial component of 
ĐliŶiĐal Đaƌe ŵeaŶt the patieŶt had to tƌaǀel to the doĐtoƌ͛s offiĐe foƌ all ŵediĐal tƌeatŵeŶt. Fƌoŵ 
the 1960s, mobile clinical outreach teams developed in high-income countries to bring care to the 
patient, although usually focused on crisis intervention.43 
Telepsychiatry, using high-speed interactive video conferencing, has shown that successful 
assessment and treatment do not require that both the patient and the clinician are in the same 
physical location (see Part 5: Digital psychiatry). 
The availability on the internet of information about psychiatric illnesses and their treatments, 
although not always accurate, has increased patient autonomy, exerting a democratising effect on 
the hierarchical doctor–patient relationship. Excellence in psychiatric care in the coming decade, 
theƌefoƌe, ǁill ƌelǇ oŶ psǇĐhiatƌists͛ skill iŶ iŶĐoƌpoƌatiŶg the patieŶt aŶd theiƌ faŵilǇ iŶ ĐliŶiĐal 
decision making. 
Personalised or precision medicine in psychiatry Personalised or precision medicine aims to refine 
prevention and treatment.42 For prevention, genomic and other biochemical or physiological 
analysis in conjunction with assessment of environmental and developmental influences should 
provide increasingly robust identification of individuals at risk for psychiatric disorders. Because of 
the intricate interactions in any individual among biological, developmental, and environmental and 
social factors, accurate prediction is not yet possible. For example, although a family history of 
schizophrenia or bipolar disorder increases risk, clinicians cannot currently predict whether a specific 
offspring will be affected. Furthermore, although living in poverty is known to put an individual at 
risk for many illnesses, including psychiatric disorders, clinicians cannot predict with precision what, 
if any, disorder will emerge in a specific person. 
For treatment, personalised medicine aims to match a patient with the most effective treatment for 
them. Pharmacological treatments for major mental disorders are at present suboptimal and often 
only a minority of patients achieve remission. Personalised medicine might be able to determine 
which patient will experience a severe side-effect from a specific medication, as is being explored 
using cytochrome P450 allele assays and other genetic characteristics to identify people who 
metabolise certain drugs slowly or too rapidly.44,45 Imaging analysis or other multifactorial 
assessment schemes not yet developed might identify, for example, those patients more likely to 
respond to psychotherapy than to medication46 or to medication as a monotherapy when 
substantial early life stress is a component.47 Innovative psychosocial interventions could be based 
on virtual reality programs48 and refinement of internet based psychological therapies that permit a 
participant to proceed at their own pace to acquire desirable psycho-logical resources. Digitally 
based suicide prevention programmes are being evaluated.49 
Despite all the conversation about a biopsychosocial approach to patient care, the field remains 
fractured between reductionist viewpoints that arbitrarily di-chotomise the mind and the brain50 
and much more complex and integrative models. 
It is difficult to conceptualise how any precision based intervention can be provided outside of direct 
interactions with a patient either in person or through a teleconference type medium. Theoretically, 
patients could be given a computer generated list of results from genomic analyses, but the 
comprehensive approach to identification of risk factors and appropriate interventions, for example, 
requires a continuous care experience in order to be effective and patient centred. 
Personalised psychiatry in the next few years will indubitably have its fair share of limitations and 
uncertainty. However, whenever large amounts of data are collected—eg, through multiple genomic 
analyses—there is the potential danger of lumping patients into very large cohorts and moving away 
from an individualised approach to maximise reproducible findings, thereby questioning the validity 
of the particular implementation of the personalised medicine approach.51 
Areas of promise 
Safer forms of medication administration or those more acceptable to patients, especially in the 
treatment of substance abuse disorders, might improve treatment outcomes through the use of 
implantable drug reser-voirs that will last for a year or longer. Nanotechnology might also contribute 
to more effective treatments. Obviously, such long duration treatments must be administered and 
monitored within the therapeutic relationship. 
The role of inflammatory processes in mental disorders is under investigation and holds great 
promise.52,53 Advances in stem cell therapy have enabled pluripotent cells to be directed towards 
defective brain areas with the aim of improving neuronal circuitry.54 This is a more distant goal for 
psychiatry: even if achieved, such a procedure should always be considered by doctor and patient in 
collaboration. 
Neuroimaging and other techniques will continue to document new regions of the cortex as yet 
undefined by traditional cyto rchitectural studies.55,56 This documentation will increase 
appreciation of the connections between different brain areas and their interdependent 
character-istics and might provide insights into autism, dementia, schizophrenia, and mood and 
anxiety disorders. 
New forms of neuromodulation might allow patients to administer treatments inexpensively and 
outside of the phǇsiĐiaŶ͛s offiĐe aŶd hospital. These Ŷeǁ tƌeatŵeŶts ŵight haǀe feǁeƌ ĐoŵpliĐatioŶs 
and risks than are often associated with, for example, electroconvulsive therapy. However, 
neurologists have cautioned against experi-mentation of do-it-yourself neuromodulation activities 
with direct current stimulation, which once again speaks to the importance of the treatment 
relationship.57 
The importance of subjectivity 
An untoward effect of the enthusiasm about the promises of scientific advances has been neglect of 
the ǀalue of the psǇĐhiatƌist͛s suďjeĐtiǀe assessŵeŶt of the patieŶt. The suďjeĐtiǀe data aďout 
ĐliŶiĐiaŶs͛ iŶteƌ­aĐtioŶs ǁith patieŶts ǁill alǁaǇs ďe keǇ to eǆĐelleŶt ĐliŶiĐal Đaƌe aŶd ƌeŵaiŶ as souŶd 
and data based as any laboratory test or imaging proceduƌe. The iŵpoƌtaŶĐe of the ĐliŶiĐiaŶ͛s 
suďjeĐtiǀe ƌespoŶses duƌiŶg assess­ŵeŶt aŶd theƌefoƌe to the uŶdeƌstaŶdiŶg of the patieŶt͛s illŶess 
narrative and treatment has been reaffirmed through recent discussions of uncertainty in clinical 
care. The psychiatrist͛s ĐapaĐitǇ to toleƌate uŶĐeƌtaiŶtǇ, as is tƌue of all phǇsiĐiaŶs, is the aŶtidote to 
a reductionist biomedical model that undermines the role of the physician. It also balances the 
unhelpful aspects of medical technology and its indiscriminate application.58 This situation is 
certainly true of the failure, so far, of the electronic medical record to live up to its promise of 
enhancing care in psychiatry and is equally relevant in assessment of the premature expectations of 
precision medicine. 
The enduring centrality of psychotherapy and psychotherapeutic skills 
The affirmation of uncertainty as a core characteristic of the physician is crucial to the acceptance of 
psychotherapy as a monotherapy and in conjunction with somatic treatments. Research into 
psychotherapy effectiveness using modern research methodologies was delayed compared with 
biological research, but has been growing for the past several decades. 
The ongoing expansion of clinical research on psychotherapy interventions, both alone and in 
con-junction with other treatments, should lead to broader acceptance of the efficacy of 
psychotherapy. Unfortunately, the paucity of resources available to deliver psychotherapeutic 
treatments and the expense and time required to train skilled psychotherapists will substantially 
ĐoŶstƌaiŶ ŵost patieŶts͛ aĐĐess to this foƌŵ of tƌeatŵeŶt. OǁiŶg to the sĐaƌĐitǇ of high­ƋualitǇ 
psychotherapy research, psychiatrists are still unable to predict for which patients psychotherapy 
will be effective, nor which form of psychotherapy will be most appropriate for a specific patient. 
The abuse of private or public personal authority and power, and its frequently associated 
psychological or economic deprivation, constitute a major source of the enduring intergenerational 
transmission of the potent and often devastating effects of psychological trauma to adults and 
children. Although neurobiological factors contribute to this human vulnerability,59 establishment of 
emotionally corrective therapeutic relationships with those who have been mistreated remains the 
most appropriate way to affirm the experience of the abused and maltreated and to confer hope for 
recovery. 
In the near future, precision medicine is unlikely to lessen the role of the therapeutic relationship 
and psychosocial interventions. Treatment of individuals who suffer trauma, endure the effects of 
social dislocation, and experience developmental vicissitudes will require skilled clinicians with the 
ability to provide psychotherapeutic interventions within the context of a strong and positive 
therapeutic relationship.60 
Subspecialisation in psychiatric practice 
The exponential increase in the psychiatric knowledge base and the literature in specialised aspects 
of patient care has necessitated and driven the rise of sub specialisation. In well resourced countries, 
the public has a high expectation of the standard and quality of health services. This expectation 
includes being treated by clinicians with expertise in a well defined field related to their illnesses. 
Both public expectations and the advances in the profession foster a rising standard of patient care. 
Benefits of having clear standards in areas of subspecialisation exist both on the societal level and 
for individuals.61 
However, progression towards increasing sub-specialisation comes with potential problems, even in 
high income countries. The first is the costs involved in development of a subspecialty and provision 
of services by subspecialties, as well as creation and maintenance of certification examinations.61 
Patients might have to pay more to see a subspecialist. Subspecialisation raises concerns about 
fragmentation of care,61 such as has occurred in general medicine. Comorbidity is very common in 
psychiatry, and the trend towards increasing subspecialisation could result in a disease based model 
of care delivery, with patients finding themselves consulting several sub-specialists. Such 
eventualities could also give rise to the development of primary care psychiatry, wherein general 
psychiatrists are viewed as having less expertise than their subspecialist colleagues. 
In LMICs, which can have less organised systems of health care and a lower expectation of centres 
providing tertiary care, a public drive for increased psychiatric subspecialisation is less likely. The 
scarcity of psychiatric and other mental health resources in such countries, as well as the 
implementation costs of a new system of psychiatric care, severely inhibit the likelihood of broad  
scale implementation of subspecialisation. 
The extreme shortage of psychiatrists in LMICs has resulted in an enormous treatment gap for 
people with mental disorders.62 Psychiatric centres in these countries are examining a different 
model of mental health service provision involving task shifting. In one model, non specialist health 
workers are trained to deliver interventions for mental disorders and dementia. In this type of 
system, psychiatrists function as public health practitioners.62 One proposal is that mental health 
should be integrated with the care of other chronic diseases and in primary care to provide more 
efficient coverage of mental disorders.63 Such an integrated care approach, often referred to as a 
mental health team approach, might reduce the pressure for subspecialisation. 
Even in high income countries, countervailing pressures against subspecialisation are likely. For 
example, old-age psychiatry has been very well developed in the UK since the 1980s. However, 
recent years have witnessed a move towards ageless services in which people of all ages are treated 
by the same clinicians. Several reasons are possible for this shift to ageless services; one is that 
combining teams would save money.64 The Faculty of Old Age Psychiatry of the UK Royal College of 
Psychiatrists lobbied the government intensively to advise against this move to ageless services, 
which might only have slowed down this trajectory of clinical system changes.64 
Over the next 10 years, pressure for increased subspecialisation is likely owing to the ongoing 
advances in the psychiatric knowledge base and increasingly sophisticated treatments, although 
with geographical and economic diversity in a dynamic process and the actual development differing 
by country. In LMICs, the needs and priorities in mental health care and the importance of 
subspecialisation are very different from those in high income countries, but even in countries such 
as China and India—which will be used to illustrate the countervailing pressures—a strong force is 
pushing towards increased subspecialisation. 
China and India account for one third of the disease burden of global mental, neurological, and 
substance use disorders.65 However, China has only just over 20 000 psychiatrists for 1·3 billion 
people—ie, 1·49 psychiatrists per 100 000 population—and India has even fewer, whereas the USA 
has around 16 psychiatrists per 100 000 people.1 As an illustration, although the National Mental 
Health Working Plan of China has set a target to increase the number of psychiatrists to 40 000 by 
2020,66 this goal risks not being achieved because of too few training programmes, even with an 
abbreviated length of training. Furthermore, the distribution of psychiatrists is very uneven in China, 
with few psychiatric facilities in the rural areas where currently about half of the population live.66 
As in many countries globally, the populations in China and India are ageing rapidly, suggesting 
strong pressure to develop old-age psychiatry specialists. Other subspecialties are being established 
in China, including child psychiatry, addiction psychiatry, forensic psychiatry, and consultation liaison 
psychiatry. These subspecialties are being implemented in urban hospitals, but are absent in rural 
areas. Quality control of practitioners is difficult because the various subspecialties have no 
certification examinations. As the major cities have become increasingly affluent, public expectation 
and demand has grown for more specialised services. Therefore, the coming decade will probably 
see increased pressure for subspecialisation in urban China. This pressure will serve as an impetus 
for improved training of a vastly increased number of psychiatrists and improved clinical services 
and raised standards of patient care. In rural China, integration of mental health into primary care 
medical services might be more likely than increased numbers of psychiatric subspecialists. 
The pace of change in patient care within all of medicine evolves slowly, and even dramatic new 
approaches might take decades to be fully implemented. Such was the case, foƌ eǆaŵple, foƌ Fƌeud͛s 
psychoanalytic theories to gain worldwide influence, and for the rising tide of pharmacology 
research starting in the 1940s to result in new medications to treat psychiatric illnesses. Barring 
unexpected revolutionary advances, we expect that over the next 10 years, patient experiences will 
continue to evolve at a pace similar to recent decades. It would have been enticing to predict 
dramatic changes, for example in understanding of brain structure and function or of gene 
environment interactional influences on brain development and functioning, and their effects on the 
understanding of the aetiology of psychiatric disorders and more detailed personalised approaches 
to treatment, including neuromodulation and gene therapy inter-ventions. However, such results 
remain speculative for now. Nonetheless, the next generation of psychiatrists is likely to see 
dramatic changes possibly more revolutionary than we imagine. 
Part 2: Psychiatry and health-care systems 
Introduction 
In most countries, psychiatry has a clinical focus—the emphasis is on individuals and individual 
disorders and health problems, rather than on the mental health needs of populations. The absence 
of a public health perspective is one reason for the huge treatment gap in most countries;67 WHO 
estimates that the treatment gap for depression and common mental disorders is greater than 75% 
in LMICs.68 Solutions to address this treatment gap require adaptation and use of public health 
models to deliver mental health care in many different parts of the world.69 The knowledge and 
expertise needed to respond to these requirements go beyond the traditional training and clinical 
background of psychiatrists. Hence, emphasis on public health in training curricula and certification 
processes is required.70,71 
However, a one-size-fits-all philosophy is unlikely to work; no universal public health model of 
mental health service delivery works in all countries. Effective models of care provision are crucially 
dependent on the availability and type of human and financial resources in a particular country,72–
75 alongside the organisation of its health care and specific mental health needs of its people.76 
The funding of health-care systems has an important influence on the practice of psychiatry and the 
provision of psychiatric care, particularly preventive and health promoting aspects of psychiatric 
care.77 A continuum exists between predominantly publicly funded, publicly delivered health-care 
systems (eg, the National Health Service [NHS] in the UK) and predominantly individual payee based, 
privately delivered health-care systems (eg, India, the USA). Although specific models might vary 
between countries, commonalities can be found when considering the place of psychiatry in the 
health-care system in a country: here, we focus on these commonalities. 
 Health-care systems in many LMICs are either poorly developed or dysfunctional.78 The United 
NatioŶs͛ ;UNͿ “ustaiŶaďle DeǀelopŵeŶt Goals ;“DGsͿ,ϳϵ ǁhiĐh ǁill ƌeƋuiƌe effiĐieŶt deliǀeƌǇ 
mechanisms to achieve health goals and are likely to bring a renewed focus on improving 
health-care systems,80 represent a huge opportunity for psychiatry. Psychiatrists need to advocate 
effectively for the inclusion of psychiatric services and to prevent marginalisation of mental health 
issues in the health-care system. 
Common factors in effective organisation of mental health care 
WHO has developed a model for optimal mixture of services (figure 1).81 The WHO pyramid model 
is based on the premise that no single service is likely to meet the service needs of an entire 
population. This model provides a relationship between different service levels (primary, secondary, 
and tertiary) and should be used when planning services in all countries, regardless of their resource 
levels. However, existing services in any country, especially LMICs, are unlikely to approximate to 
this model of service provision. Irrespective of the country situation, any efforts to improve the 
service provision model require a good understanding of the existing mental health system and how 
to build, reshape, and decentralise the existing system to meet local needs. 
Apart from an optimal mixture of services, the following should be considered when planning mental 
health services for a population: 
(1) Episodic versus continuous care: health care, especially primary and secondary health care, is 
often organised around the treatment of communicable diseases that presumes the need for 
treatment of an acute episode followed by remission or recovery and no care requirement until the 
next episode of illness in the same individual or another individual. However, episodic care models 
poorly address the needs of many people with severe mental illness who are likely to have 
continuous illness with episodic exacerbations. Their care needs are better addressed by continuous 
care models that take the long term nature of their illness into account. 
(2) Needs led versus service led models of health care: in many countries, services are organised 
from a managerial perspective of service providers rather than through consideration of patient 
needs and abilities. Many people with mental health problems struggle to navigate separate health, 
mental health, and social care services that are organised in vertical silos with their own criteria and 
priorities for whom they serve. A needs led model of service delivery will necessarily take user needs 
into account and provide a seamless flow within health services and between health and social 
services. 
Pathways to care 
A common characteristic when looking at pathways to mental health care is the glaring absence of 
such pathways in many countries, particularly in LMICs.82 The arrival of a patient to the psychiatrist 
might not always be straightforward and direct. A common denominator in both high income 
countries and LMICs is the possibility of delay—sometimes months or even years—before a person 
reaches the specialised professional.83 Obstacles to the provision of proper care in the shortest 
possible time include the following: 
(1) In LMICs, rural areas, or specific communities in high income countries, people with mental 
health problems are likely to seek the help of a traditional healer or religious adviser as a first option. 
If their symptoms continue or get worse, often after many months, these people ultimately reach a 
psychiatrist or another mental health professional, with an accumulation of negative consequences 
of delayed treatment.84 
(2) When the only available services are old style mental hospitals, frequently on the outskirts of 
main cities, with a negative image of poor quality care, people with mental health problems are less 
likely to access them unless severely ill or with disabilities.85 
(3) Stigma and discrimination can result in absent or inappropriate services at community level, 
worsening the access to possible pathways to care.86 The relation between stigma and help seeking 
is often underestimated, particularly in children and adolescents.87 Gender stereotypes also shape 
the path to specialised care in different ways for men and women.88 (4) People with different 
cultural and religious backgrounds or sexual or gender orientation have differing needs and 
perceived obstacles to approaching conventional mental health-care services. Inadequate cultural 
sensitivity within a health-care environment (eg, no prayer rooms for patients of different faiths) and 
insufficient cultural competencies in mental health professionals (eg, services that do not address 
specific needs of lesbian, gay, and transgender communities) can result in reduced acceptability and 
accessibility of services for these populations. 
Despite these barriers, evidence indicates that the implementation of care management processes 
and collaborative chronic care models can facilitate pathways to care and ultimately improve 
outcomes for chronic mental illnesses.89 Some strategies can reduce the delay for people with 
mental health problems in accessing proper services (panel 2). 
Psychiatrists in primary, secondary, and tertiary health care 
Until a few decades ago, psǇĐhiatƌists͛ aĐtiǀities aŶd psǇĐhiatƌiĐ pƌaĐtiĐe iŶ ŵost ĐouŶtƌies ǁeƌe 
largely confined to old style mental hospitals. With increasing evidence of negative effects of 
institutionalisation91 and of improvement in negative symptoms and social network upon 
resettlement of long term hospitalised patients into community care,92 mental health care in high 
income countries (and some LMICs) has moved out into the community and into the general health 
system.93 Patients with mental health problems no longer have to be treated at a mental health 
setting but might be seen by a psychiatrist in a general hospital, a community clinic, at home,93 or, 
in the unfortunate circumstances of homeless people with mental illness, on the streets.94 
However, owing to various political, cultural, and health-care structural reasons, in some countries 
standalone mental hospitals remain the only mental health-care provision. Although some of these 
hospitals have undergone substantial improvements in hospital environment and governance 
structure, many are still plagued with problems of institutionalisation, inpatient suicide, and human 
rights violation.95 Notably, continued dominance of large mental hospitals in many countries does 
not facilitate evidence based interventions, such as services delivered in decentralised locations, 
integrated within the community, and supported by appropriate referrals to secondary and tertiary 
care systems.96 
The change in care model in some countries inevitably needs to be accompanied by a radical change 
in the relationship between psychiatrists and other mental health professionals, from a paternalistic 
model to a new teamwork model. In the past, psychiatrists were considered the core professional 
group providing medical treatment whereas other mental health professionals were merely 
expected to execute treatments prescribed by psychiatrists. However, in the new model in which 
mental health interventions for common mental disorders are increasingly delivered in the primary 
care sector by other health professionals, psychiatrists now play the role of trainer and supervisor of 
these health professionals, both in the implementation of evidence-based psychosocial interventions 
and in decisions on the appropriateness of referrals to secondary or tertiary psychiatric care. Scarce 
resources for mental health care in LMICs (panel 3) have led to the trend of 
 
 using and engaging with informal human resources, such as peer support, volunteers, family 
members, and caretakers (eg, Basic Needs, a mental health organisation providing and promoting 
informal community care). Thus, psychiatrists need to be trained not only in diagnosis and 
management of a wide variety of mental health problems, but also in supervision, training, and 
dissemination of relevant psychiatric skills and knowledge to other health and non-health 
professionals (see Part 6: Training the psychiatrist of the future).107 
Psychiatrists working in secondary care should work in general hospitals or community settings and 
work with different professionals, including community nurses, counsellors, social workers, and even 
housing managers. Growing evidence shows that many patients with mental health problems have 
increased rates of untreated medical comorbidities including hypertension and obesity;108 some of 
these comorbidities are related to the side-effects of newer psychotropic medications,109 as well as 
the fact that people with chronic medical illnesses have increased prevalence of mental illnesses.110 
As a result, psychiatrists need to be prepared to work closely with general health specialists. 
Psychiatrists also need to be trained in diagnosis and management of common communicable and 
non-communicable diseases so that they are equipped to manage common medical problems in 
patients with mental illness under their care. 
Tertiary care services such as specialised services for eating disorders, severe personality disorders, 
and forensic psychiatry are equally necessary but poorly provided in most countries.111 Without 
appropriate secondary and tertiary care services, patients with complex needs risk being 
trans-institutionalised or incarcerated in correctional institutions such as prisons.92 Implementation 
of a stepped care model requires an adequate workforce of trained mental health specialists 
including psychiatrists, changes in training curricula for primary care and mental health-care staff in 
the community, and a change in health-care delivery models. Poor government commitment, a 
paucity of mental health policies, and insufficient legislations for respect of human rights are some 
major barriers to the implementation of such improvements in mental health service delivery.96 
Psychiatrists working in the tertiary sector are also expected to take up a role as leader of a 
multidisciplinary team with specialised skills in management of complex mental disorders (eg, eating 
disorders, severe personality disorders). Apart from having highly specialised knowledge and skills in 
the diagnosis and management of such patients with complex needs, psychiatrists need leadership 
skills to influence and unite various mental health professionals to work as a cohesive team, 
especially during crises for patients under their care. The described knowledge, skills, and attitude of 
working with different stakeholders in the community and in general medical health settings need to 
be cultivated and imparted during undergraduate and graduate psychiatric training. 
Psychiatry thus needs to be integrated both vertically and horizontally into the general health 
system. Models of integration focused on hospital based inpatient and outpatient care alone do not 
ensure access and continuity of care, whereas exclusively community based services cannot provide 
comprehensive treatment. Hence, a balanced care model is the best choice, requiring a revision of 
the roles of mental health professionals.112 Mental health professionals including psychiatrists 
could work directly in secondary and tertiary services, providing consultation liaison for complex 
cases, training and supervising primary care staff to augment their ability to identify and treat 
people with mental illness, and assessing and treating outpatients and inpatients who cannot be 
managed in primary care.113 Such balance requires collaborative linkages with colleagues from 
different specialties114 and close interactions with other sectors beyond health,115 including a 
much more broadly defined social care sector—for instance, comprising social welfare, education, 
and justice.116 
Governance, leadership, and coalition building 
The change in the psǇĐhiatƌist͛s ĐliŶiĐal ƌole oǀeƌ the past tǁo deĐades as paƌt of 
deinstitutionalisation worldwide117,118 requires that they engage in regular interactions with 
health authorities and other professionals, to promote and design new policies and programmes and 
to contribute to the search for additional financing119 (see Part 6: Training the psychiatrist of the 
future). It also requires reorganisation of services and development and dissemination of new 
guidelines and procedures to facilitate collaboration among its multiple components.120 
A psychiatrist will have to build alliances, learn to work as part of a coalition with other health 
professionals, and alter the traditional isolation of psychiatry.121 Working with others helps to 
overcome the fragmentation of services provided to patients with diverse needs, and also 
contributes to reducing the isolation and stigma associated with psychiatry.62,122 Psychiatrists need 
to appreciate the strengths and values of different stake-holders, articulate their views in a language 
free from medical jargon, and lobby, negotiate, and compromise with stakeholders with contrasting 
views to devise optimal care plans for their patients. 
To achieve these changes, appropriate stewardship of mental health and psychiatric care in 
governments75 is required. In some countries, a mental health department or unit is part of the 
organisational structure of the ministry of health, facilitating and ensuring interaction with other 
units and programmes, thus easing potential collaboration and integration of mental health related 
issues with other health sectors and programmes. In other countries, particularly in low resource 
settings, just one person might be in charge of the mental health programme, highlighting the 
importance and urgency of coalition building.123 In all situations, psychiatrists need to be equipped 
with the skills and insight necessary to effectively lobby, negotiate, and promote the values of 
mental wellbeing of the population to the relevant parts of the government.111 Working with 
others and ensuring that people with mental health conditions are comprehensively being taken 
care of would put psychiatrists in a better position to reinforce their professional identity and 
related core skills.124 
Financing and resourcing 
Resources are finite and insufficient to meet all care needs in all health-care systems globally. 
Psychiatrists, as key stakeholders and advocates, require training to meaningfully engage in relevant 
discussions to advocate for both absolute increases in resources for mental health care as well as 
more appropriate reallocations of existing scarce resources. To achieve this, psychiatrists need to 
widen their knowledge of the health system beyond their own clinical area and expand their 
understanding of health-care financing and strategies to secure more resources—eg, use the push 
from large-scale actions such as the SDGs to secure further funding or changes to the health-care or 
health-care financing systems; secure ring fencing of funds for vital mental health care; or better 
integrate mental health care into related clinical contexts that are better recognised and 
resourced125 (such as physical health conditions that carry substantial mental health comorbidities). 
Although absolute increase in mental health funding must remain a key goal, making the most of 
current resources is an important continuing challenge. Resources should be seen in terms of the 
value they can provide towards achieving the goals of the health-care system, whether they be 
improving population health, improving welfare and broadening its definition, or other societal aims. 
Such comparisons of value can be made either within a specifically defined population or across 
populations and communities. For example, consider a situation in which psychiatrists successfully 
secure increased funding for expansion of a mental health-care facility. Perhaps another form of 
care, such as training of community based lay workers, would have resulted in better outcomes for 
the community as a whole, or in more equity in access to care. Several effective and low cost 
interventions addressing childhood mental health problems could be self financing over time with 
pay-offs to the public sector and elsewhere—eg, improved educational performance, employment, 
or earnings, and reduced crime.126 
Health economics offers concepts and frameworks to help to formalise such complex considerations. 
One approach is the explicit consideration and comparison of both inputs to and outputs from care 
and the relationship between them—ie, the assessment of efficiency—to direct scarce resources to 
interventions that work and are cost effective. This might necessitate redirection of existing 
resources from their current use (ie, disinvesting), if these resources could provide better value 
elsewhere. Resource allocation can be considered suboptimal against not only the economic criteria 
of efficiency and equity, but also a range of other social, ethical, and moral criteria. For example, in 
many countries, 80–90% of the mental health budget goes to mental hospitals,127 even though 
many stake-holders consider institutionalisation to be inhumane.128 Addressing such 
multidimensional issues requires a collaborative approach. Adoption of narrow perspectives risks 
cost shifting between sectors and budgets, whereby savings are either not felt in the area in which 
an intervention is provided (which then requires greater cooperation to avoid reduced incentives to 
provide that care) or savings are felt in the intended area but with an associated increase in costs or 
burden elsewhere that is unaccounted for. 
Implementation and scaling up of evidence-based care is a priority for the strengthening of mental 
health systems.68 Reliance on arguments without an evidence base, with a low-quality evidence 
base, or with an evidence base without appropriate attention to translation across different contexts 
can lead to erroneous decisions that benefit neither patients nor the health-care system. Therefore, 
the ability to generate new evidence; find, understand, and critically interpret such evidence for 
quality and relevance; and use and communicate evidence effectively is an important skill set in 
itself. Psychiatrists should be encouraged to learn such a skill set to enhance both their knowledge 
and persuasive abilities towards improving mental health systems. 
Conclusion 
Mental health-care models differ around the world due to history, culture, and availability of 
financial and human resources. Many of these models are not necessarily evidence based and might 
not be either effective, efficient, or acceptable to service users. The WHO pyramid model and the 
associated notions of stepped care, teamwork, and integration of mental health into general health 
care are widely considered to provide a good template when contemplating reform or development 
of mental health services in different countries. Within this broad international framework, 
individual treatment strategies and the use of human resources (professional vs peer or lay health 
workers) in different countries will need to respect individual values, culture, and the availability of 
financial and human resources. This diversity should be respected and encouraged to ensure that 
service provision in different countries is locally relevant. Enhancement of psychiatƌists͛ skills to 
facilitate and lead these changes in mental health service delivery across the world is urgently 
needed. 
Part 3: Psychiatry and society 
Introduction 
The state and extent of mental health care and the role of psychiatrists within it vary substantially 
across the world. In most industrialised countries, the past five decades have seen a transformation 
of psychiatric service delivery. Although the exact time of onset, political drivers, pace, and 
outcomes of mental health-care reforms in these countries have differed, the general shift has been 
from institutional forms of care that were centralised and isolated towards more community centred 
services. Such community centred services tend to be characterised by small units in accessible 
settings, working in close partnership with social care services. Overall, service capacity has 
expanded. Many more patients in industrialised countries receive some form of mental health care 
compared with 50 years ago. The quality of facilities tends to be better, and the number of mental 
health professionals—including those with a full qualification—has grown substantially. These 
improve-ments are a result of increased investment linked to growing interest in mental health care 
in these societies. 
These changes have affected the role of psychiatrists in the delivery of mental health care. 
Psychiatrists frequently work with other mental health professionals in a multidisciplinary 
collaboration. The work of psychiatrists has often focused on traditionally medical competencies 
such as psychopharmacological treatment and physical aspects of mental disorders. Yet, little 
progress has been made in psychopharmacological treatment in the past 30 years, whereas 
psychological treatments are often studied and administered by a growing number of clinical 
psychologists. This situation challenges the central expertise of psychiatrists in mental health care 
and requires adjustment of the focus of core competencies and tasks. Increased emphasis on social 
interventions and engagement with societal expectations might be one way forwards for the next 10 
years. 
The role of psychiatrists in society 
Psychiatrists have a long history as a profession. During the age of enlightenment, the term 
psychiatry was coined. Psychiatry soon became a separate specialty within medicine and the 
profession of psychiatrists was established. Thus, medical doctors with the title psychiatrist have 
been part of the profession for about 200 years. The exact function and role of psychiatrists has 
changed over time and is different across the world.129 As a profession, psychiatry had a role in 
regulating itself and deciding on acceptable practice, but it has also been subjected to strong societal 
pressures, influenced by moral judgment, and controlled by legislation. Different groups in society—
including the general public, the media, and politicians, as well as patients and their families—have 
expectations as to what the tasks and authority of psychiatrists should be. These expectations 
influence regulations for and funding of psychiatrists, shaping their roles and contributing to a 
contract with society.130 Roles typically include treatment and care of people who are considered—
according to the ideas of the time—to be insane, mentally ill, or distressed. Yet, the roles also 
include functions of social control and risk containment of people who are both considered 
dangerous and mentally ill. The threshold and balance is again subject to values and tolerance 
prevalent at the time, associated with stigma and perception of fear. This tension between 
therapeutic aspiration and social control has characterised much of the history of psychiatry and can 
be assumed to continue for at least the next 10 years. 
The role of the psychiatrist has always included the authority to initiate treatment against the will of 
some patients, although, depending on the exact regulations in different countries, the actual 
involuntary treatment might require the endorsement of other authorities. Psychiatrists have been 
given this power by society, commonly in the form of legislation. This authority implies a duty of 
protection of both the individual and society, with a balance of human rights and prevention of 
violence that poses a constant challenge and will continue to do so. The pendulum is constantly 
swinging, with different groups in society pulling in opposite directions. In one direction is an 
emphasis on the rights and autonomy of disabled people and their implications for mental health 
legislation, which, according to some interpretations of the UN Convention on the Rights of Persons 
with Disabilities (CRPD), might be incompatible with coercive treatment.131 In the other is the 
increasing pressure by some governments and the media to report people to the police who might 
pose a threat to public safety and to protect society from potentially dangerous behaviour of people 
with mental disorders. Both arguments appear to gain ground simultaneously, and these pressures 
will continue (see Part 4: The future of mental health law). Psychiatrists find themselves caught in 
the middle, at risk of being blamed by both camps. They can feel uncomfortable with their role in 
exerting formal coercion and also with use of so-called informal coercion, in the form of persuasion 
and other behaviour to influence patients to accept treatment suggestions.132 The arising tension 
and uneasiness are part of the practice of many psychiatrists and should be explicitly addressed in 
public, professional debates, and clinical training and supervision. 
Psychiatrists are considered to have a general societal role as the arbiters of mental sanity. This role 
includes the task to distinguish between mad and bad, and the wider challenge to define mental 
normality and abnormality. Psychiatrists are challenged to identify which type and extent of mental 
distress and problems with performance in education and work constitute a mental disorder and 
which ones do not. The underlying concepts of mental disorders and the specific diagnostic 
classification systems used are subject to constant debate and vary across the world. In a globalised 
world, the question arises as to whether there should be one agreed way of making diagnoses or 
whether global variation of mental disorders warrants different approaches based on a dialogue 
with local society. Moreover, as the world sees increasing immigration, mass movements of 
refugees, and international travel, psychiatrists will often need to be competent in assessment of 
mental disorders across different cultural groups and in different societal contexts. Such 
competence might require an increasing ability to understand and communicate the processes that 
led to diagnostic categories to support their legitimacy.133 
The role of psychiatrists in societies includes also a general task to stand up for the rights, dignity, 
and inclusion of people with mental disorders. This task is based on social values and might be seen 
as essential for the credibility of a helping profession. It involves commitment and activities against 
the discrimination of people with mental disorders and in support of their social inclusion.134,135 
Social inclusion requires appropriate legislation securing the rights of people with mental disorders 
to receive appropriate care, material and practical support—eg, in the form of protected 
accommodation and specific work arrangements—and to participate actively in societies. However, 
formal legislation alone cannot fully prevent social disadvantage and marginalisation. People with 
mental disorders are more easily integrated and respected if the general population holds positive 
attitudes towards them. So far, research has yielded little evidence as to how psychiatrists can 
influence these attitudes in public campaigns.136 The next 10 years should see more systematic 
research on how the public should be informed about mental distress and mental disorders, so that 
better initiatives can be designed to build on and strengthen caring attitudes and integrative 
behaviour towards people with mental disorders in general populations. 
Multidisciplinary status and role 
Psychiatrists are not the only experts in mental disorders and in the different approaches that can be 
used to help and support people with mental disorders. Other workforce groups such as clinical 
psychologists, nurses, occupational therapists, arts therapists, and social workers have their own 
expertise and contribute to a wide range of treatments in multidisciplinary settings. The specific 
status and role of psychiatrists within the multidisciplinary role is fluid, both over time and across 
countries and settings. Constant adaptation is required, and occasionally this can threaten 
professional roles and status, especially when traditional monopolies such as prescriptions of 
medication are affected by extension of these rights to psychologists or nurses. Status, role, and 
level of specialisation are shaped by factors related to the structure and delivery of mental health 
services, professional respect, fashions of treatment, and economic opportunities, all of which are 
affected by public opinion through political processes such as laws, regulation, and resource 
allocation. 
A central factor for the specific role of psychiatrists is the overall number of psychiatrists per 
population. In highly resourced health-care systems with large numbers of psychiatrists, their role 
can include wide responsibilities in the direct delivery of care and a large degree of specialisation. 
However, in countries with low spending on mental health care and low specialist clinical capacity, 
people with little specific mental health training might need to identify mental disorders and provide 
treatment as part of their jobs. There, the role of psychiatrists might be more focused on the 
development of protocols and services, support of staff, quality control, consultancy on the most 
challenging patients, leadership, and advocacy. 
The political role 
A large body of evidence shows the importance of social determinants for mental disorders.137 
Societal factors such as social inequality, crime, poverty, poor housing, adverse upbringing 
conditions, poor education, unemployment, and social isolation are related to increased rates of 
mental disorders.138 The relevance of some social determinants varies across the world.139 
Examples are substantial urbanisation in LMICs; increasing social isolation in high income countries; 
the changing flow of refugees in some regions; and different levels of economic instability, civil 
unrest, and inequality between rich and poor people. Most of these social determinants influence 
physical health problems too, but they can be seen as particularly relevant to psychiatry.140–144 
Psychiatrists are not ignorant of the complex interface of the manifold interactions between such 
social determinants and mental disorders. The challenge is how to improve such determinants, most 
of which cannot be changed by individual psychiatrists and the interventions available to them. 
Many psychiatrists are aware that antidepressants are palliative at best for a woman with 
depression living with several young children in poverty in a destitute neighbourhood and being 
subjected to abuse from an unemployed man with an alcohol problem. Referral to a social worker, if 
available, is an obvious option, but hardly addresses the root of the problem. The question is what 
role psychiatrists can take to improve conditions essential for overcoming mental distress.145 
Should psychiatrists be involved in changing social determinants or should they limit themselves to 
remain doctors who treat mental disorders of individual patients? 
One argument is that a change in these factors is mainly a political task. Some tasks such as alcohol 
pricing might be seen and supported as specific public health actions on a country or regional 
level,146 whereas others will have an even wider reach and go beyond a debate on public health. 
Measures that will achieve poverty reduction or less inequality require a redistribution of wealth, 
child-care provision for the poor needs public spending, and only legislation and funding 
programmes can ensure that all employees receive a living wage and have access to appropriate 
housing. These are far reaching political tasks and interventions, beyond the direct influence of 
psychiatrists. 
Nevertheless, psychiatrists—as individuals or as representatives of larger organisations—might 
regard it as their role to advocate and lobby for broader societal actions that could have a beneficial 
effect on the mental health of the population in general and people with mental disorders 
specifically. With their expertise in how social processes affect mental health and with the societal 
status of the medical profession and science, psychiatrists can have credibility and influence in a 
political debate on how to improve the mental health of societies. The influence can be stronger 
when psychiatrists raise their voices in representative professional associations and jointly with 
other groups in society—eg, those rep-resenting patients, families, or other professions. 
Other, more specific political debates and decisions are also central to and directly affect the work of 
psychiatrists. Political decisions are required on professional regulations and funding arrangements. 
Central or local decisions are taken on what type of services and treatments to prioritise, whether 
this be where to invest at times of growing investment in health care or where to reduce services in 
times of austerity. Psychiatrists have a role and expert voice in these debates and should inform 
these decisions. Their influence could be particularly strong if they are seen as not primarily pursuing 
a parochial professional advantage, but as acting in the interest of patients, their families, and the 
wider public.147 
Working with communities 
A general political commitment can be only one aspect of the societal role of psychiatrists. Central to 
the work of psychiatrists is the need to provide and oversee direct care for their patients. Although 
they will often be aware of the importance of the social factors and potential problems of their 
patients, the question arises whether changing these factors and addressing these problems in the 
given context of their patients is within their professional responsibility.148 Should a comprehensive 
psychiatric treatment plan include arrangement of employment or help to get out of poverty, or 
should these be considered separate tasks? In principle, the same question arises for other medical 
professions. Is it the role of an oncologist, for example, to assess and address the social isolation of a 
patient with cancer, because such isolation is a major predictor of reduced life expectancy in 
oncological patients? One argument could be that if psychiatrists aim to be the leading experts in 
helping people to overcome mental distress, they need to understand and address social factors. 
Although psychiatrists cannot become social workers, the challenge is for them still to be experts in 
assessment of social problems and resources, and in initiation, overseeing, and evaluation of change 
in the social situation of their patients.149 
Working not only in, but also with, communities is a serious challenge that varies depending on the 
type of communities with which psychiatrists might work. The challenge can change rapidly—eg, as 
stipulated by the massive trend towards urbanisation across wide parts of the world or by sudden 
influxes of large refugee groups.150 Working with communities can involve mental health 
promotion and prevention activities, focusing on groups at risk such as young mothers and people 
from socially marginalised groups; linking with faith communities and their networks; working with 
employers to improve conditions that put people at risk of mental distress at their workplace and 
implement procedures for support in case of signs of mental disorders; and lobbying housing 
providers and local authorities as well as supporting local community activities to foster better social 
integration of patients with severe mental disorders. More research is required to decide whether 
other potential initiatives, such as discussions in schools about mental distress and ways to 
overcome it (eg, the MindMatters mental health initiative), should be implemented and, if so, how 
best to do this. 
Psychiatrists might have to learn how to analyse the social situation of a patient, evaluate the 
resources in a family and local community that can be used to overcome mental distress, and 
identify potentials for beneficial interventions and support.151 In collaboration with patients and 
their families, psychiatrists can then design interventions, be involved in their implementation as 
appropriate, and have methods to evaluate the outcomes on the level of affected groups and 
individuals. These steps will require working with local communities, services, and authorities, and 
might change the current focus on individualised treatments, instead emphasising the therapeutic 
potential of groups and communities.152 In many societies around the world, as a consequence of a 
shift from rural lifestyles to industrial work and urban expansion, loneliness and social isolation are 
increasing and causing prominent social problems, which affect mental as well as physical health. All 
these issues raise urgent questions as to how psychiatrists can best use their expertise and social 
status to initiate community cohesion. 
Many peer support schemes153 and befriending schemes154 through volunteers have been set up 
to address the isolation or social exclusion. Such schemes can be valuable to both the patient 
receiving the support and the peer or volunteer providing it. Moreover, the schemes might also 
benefit communities by linking different groups, thus increasing social cohesion and social capital. A 
range of schemes exist across the world, although they can be difficult to sustain owing to little 
expert input and organisational support. 
In low-resource societies, the situation is very different and much more challenging. The number of 
psychiatrists can be as low as 0·1 per 100 000 population, with hardly any specialist mental health 
resources for individualised treatments.155 
In various LMICs, people with severe mental disorders can be hidden by their families or local 
communities, without access to health services, and sometimes chained up for years.156 A role for 
psychiatrists is to find such patients, challenge and change inhumane practices by families, and offer 
treatment and support instead. Some studies have suggested that psychiatrists and other mental 
health professionals can create social support systems by training lay people to support families and 
communities, so that patients receive basic emotional and social support to overcome or reduce 
their distress.157,158 This approach requires a very different model of working from the individual 
treatment approach practised by psychiatrists in resource rich countries. Instead, they need to 
consider carefully how their rare expertise can be used most efficiently. Psychiatrists need to be 
coordinators, supervisors, and trainers with an indirect rather than direct effect on people with 
mental disorders. They need to work with existing networks, such as families and faith communities, 
and other available support systems, such as healers and lay counsellors.62,159,160 Over the next 
10 years, the small number of psychiatrists in low resource countries should focus on such roles, 
rather than concentrate in large capital cities and provide private care to a small group of rich 
patients. 
A focus on working with families, groups, and communities (eg, the Mental Health Innovation 
Network) rather than on individuals within them can be particularly appropriate and beneficial in 
societies that are more collectivistic (or family centric) as opposed to more individualistic (or 
egocentric) societies. 
Social media 
In areas where face-to-face contact with psychiatrists is difficult or not feasible, telepsychiatry is 
increasingly used as an alternative. However, the potentials of technologies go beyond this. 
Increasingly, social relationships can be online. Research suggests that patients with mental 
disorders often extensively use the internet and online networks.161 Psychiatrists cannot ignore this 
and should find ways to support their patients in this changing context as well as help them to use 
the new possibilities in social media and the virtual internet world.145,162 Technological progress 
might also allow many patients to access psychiatrists via the internet across the world, at any time, 
and wherever the patients are. This development might lead to a consumer dominated market of 
different types of psychiatric expertise with very variable forms of patient–psychiatrist relationships. 
Training 
Psychiatrists migrate across the globe. Anecdotally, it is said there are more African psychiatrists in 
the UK than in Africa. Yet it is questionable whether the education and training psychiatrists receive 
are preparing them to work in different cultural and social contexts. Some shared curricula might be 
helpful, although the challenges of standardisation are formidable.163 
To work in and with societies, psychiatrists should know how to campaign and advocate, and have 
negotiating and mediating skills, which can be learned in training. To a different degree, some 
curricula have already incorporated specific training in advocacy, communication with the wider 
public, and taking a role in the wider society.164 Such training components could be expanded and 
made more comprehensive as a core part of the training of psychiatrists. 
Psychiatrists still receive most of their training in hospital settings. A survey of training in 33 
European countries suggested that in only 12 of them some rotation into a community setting is 
required, usually with a duration of 2–6 months.165 If psychiatrists are expected to work more in 
the community, they should also receive more training in such a setting. 
Psychiatrists should also receive training in social sciences as an important basis of psychiatry in 
addition to the more biological basic sciences.145 Training in the next 10 years could also emphasise 
more skills in interpersonal communication and the management of social groups in different 
contexts. 
Conclusion 
The main task of most clinical psychiatrists will continue to be the treatment of individual patients. 
However, psychiatrists have and will continue to have a wide role in society, ranging from a potential 
political commitment to practical working with communities. This role will vary substantially in 
different countries and different societal contexts, and probably remain fluid and controversial. All 
of these factors can make working as a psychiatrist challenging and at times frustrating, but also 
exciting, socially relevant, and deeply rewarding. 
Part 4: The future of mental health law 
Introduction 
The notion that people with mental illness need protection has evolved from teachings of ancient 
civilisations to guidelines for asylum management through to national policies and, finally, mental 
health legislation. 
In some jurisdictions, such as in the UK, mental health legislation has changed from concern with 
removing people with mental illness from the streets to the need to provide a safe and caring haven, 
and then to the need to safeguard and protect the rights of people with mental health problems. We 
will use the progression of mental health law in the UK to illustrate this change, accepting that 
although some aspects are generalisable to other legislations, some will be of more parochial 
interest. Our aim is to assess mental health law, outline the issues, and suggest a new way forwards 
for the next 10 years. 
200 years of mental health law in the UK 
In 1808, the County Asylums Act was the first legislation specifically dealing with the treatment of 
those with mental health problems. It required the establishment of institutions (asylums) to 
provide treatment and refuge for people with mental health problems. This legislation was 
strengthened in 1845 when the Lunacy Act established the Lunacy Commission to ensure the 
building and inspection of asylums in each county. All asylums had to be registered with the 
Commission, have written regulations, and a resident physician. This legislation had a humane 
underpinning being borne out of concerns around how people with mental illness were being 
treated. 
In 1890, the remit of the asylums was widened: rich people could now be admitted to asylums and 
reception orders were developed that allowed a person to be admitted for 1 year (signed by a 
JustiĐe of the PeaĐe, oƌ MagistƌateͿ. A peƌsoŶ had to ďe ͞Đeƌtified iŶsaŶe͟ ďefoƌe theǇ Đould ďe 
admitted, but this certification was on the order of the parish doctor rather than the specialist 
asylum doctor, who had little control over who was admitted to their institution. These reception 
orders could be renewed with the agreement of the Lunacy Commission following the provision of a 
suitable medical report. In 1913, the Lunacy Commission was renamed the Board of Control for 
Lunacy and Mental Deficiency and its powers widened considerably. A Royal Commission on Lunacy 
and Mental Disorder, established in 1924, reviewed the care of people with mental health problems 
following widespread condemnation of the conditions within asylums, with many people being left 
foƌ loŶg peƌiods ǁithout ƌeǀieǁ aŶd eǆtƌaoƌdiŶaƌilǇ high death ƌates. The CoŵŵissioŶ͛s fiŶdiŶgs, 
published 2 years later, were that the distinction between mental and physical disorder was largely 
artificial and it recommended greater overlap. 
In 1930, the Mental Treatment Act allowed voluntary admissions to mental hospitals (the new name 
for asylums) and outpatient treatment. By the 1950s, improvements in mental health treatment 
increased the probability of recovery. In 1957, the Royal Commission on the Law Relating to Mental 
IllŶess aŶd DefiĐieŶĐǇ ƌeĐoŵŵeŶded that ͞Ŷo patieŶt should ďe ƌetaiŶed as a hospital iŶpatieŶt 
ǁheŶ he has ƌeaĐhed the stage at ǁhiĐh he Đould go hoŵe͟.ϭϲϲ UŶtil ϭϵϱϵ, adŵissioŶ to hospital 
had come under the auspices of a judge. The Mental Health Act 1959 allowed for admission to 
mental hospital to be a medical decision and, if compulsory, under a proper legal framework. 
For the first time, there was a requirement for appropriate treatment to be available in order for a 
person to be detained against their will. 
The Mental Health Act 1983 sought to bring mental health law in line with the European Convention 
on Human Rights. The provisions of the 1959 Act did not include sufficient safeguards around the 
arbitrary detention of people with mental illness and consent to treatment (for both voluntary and 
detaiŶed patieŶtsͿ. The ϭϵϴϯ AĐt ƌeƋuiƌed the speedǇ aŶd ƌegulaƌ ƌeǀieǁ of a peƌsoŶ͛s deteŶtioŶ. 
The introduction of approved social workers whose role was to ensure that the rights of the patient 
were properly adhered to was a key advance: the rights of the individual were being brought to the 
forefront of mental health law. 
The most recent legislation covering England and Wales, the Mental Health Act 2007, introduced 
supervised community treatment, including community treatment orders. Unlike the 1983 Act, 
which specified the types of mental disorder required for detention, the 2007 Act does not, 
prompting concerns that this new umbrella definition would catch all manner of mental disorder, 
including autism and substance use disorders, which were precluded with the 1983 Act. Although 
guidance clarified that people with primary alcohol and substance use disorders were not liable for 
detention and those with learning disability had to have abnormally aggressive or seriously 
iƌƌespoŶsiďle ĐoŶduĐt assoĐiated ǁith theiƌ disaďilitǇ, seǆual deǀiaŶĐǇ aŶd Aspeƌgeƌ͛s sǇŶdƌoŵe aƌe 
included in the definition of mental disorder. Therefore, even transgender people could be detained 
under the Mental Health Act 2007. As such, the new definition was felt to be over inclusive. Most 
ĐoŶtƌoǀeƌsial ǁas the ƌeŵoǀal of the ϭϵϴϯ AĐt͛s ƌeƋuiƌeŵeŶt that the ŵeŶtal disoƌdeƌ ďe tƌeataďle 
and its replacement with the criterion that appropriate medical treatment has to be available.167 
Moncrieff has complained that the 2007 amendments to the 1983 Act were driven by a fear of the 
risk of violence posed by a very small group of people with dangerous and severe personality 
disorder.168 
A large proportion of detentions under the Mental Health Act in the UK are driven by concerns about 
the risk a person might pose to themselves and particularly to others, yet the primary method used 
to determine this—unstructured clinical judgment—is a poor predictor of risk.169,170 Although 
having a mental health problem is associated with a much higher risk of self harm than in the 
general population, this is not the case for risk to others. Even in those with severe mental illness 
(such as psychosis and schizophrenia), although the risk of self harm or suicide is 7·2 times the risk in 
the reference population,171 the risk of behaving violently is only 1·2 times that of the general 
population.172 Over-reliance on unstructured clinical judgment might result in more people being 
detained under the Mental Health Act than is necessary. Overuse of mental health legislation has 
substantial resource implications. The estimated cost for a voluntary admission in the UK is about 
£12 200 based on a median length of stay of 38 days. A 2012 report173 found that involuntary 
(compulsory) admission under the Mental Health Act is associated with an increased length of stay 
and involuntary admissions are likely to be far more expensive because they are usually longer. The 
report concluded that the availability of more and better interventions outside of the hospital 
inpatient setting would help to reduce such costly admissions. 
A more evidence based approach to mental health law would probably result in greater focus on 
health need rather than on risk. Such an approach would increase access to appropriate evidence 
based care in the least restrictive setting for that individual at that particular time. A focus on health 
need would identify those with mental health issues that increase their risk to themselves or others, 
and allow for them to be treated under section of the Mental Health Act. Together with legislation 
that focused on ensuring that appropriate treatment options were available in the most appropriate 
setting, this approach would probably not only reduce the numbers of people to be detained 
unnecessarily or for longer than necessary, but might well have substantial cost benefits. 
An evidence based approach to mental health legislation should be designed around health need 
and improving outcomes. Mental health legislation should mandate access to good quality mental 
health services and care in whatever setting is most appropriate for that individual at that time; 
provide recognition of and protection against abuse (from carers, mental health providers, and the 
state); and be based around ensuring that the will and preferences of the individual are given high 
priority. 
The problem with existing mental health law 
The problem of mental health legislation and human rights The CPRD174 is an international human 
rights treaty, binding in international law on countries such as the UK that have signed and ratified it, 
intended to protect the rights and dignity of people with disability, including psychosocial disability 
(see appendix for more detail). The CRPD sets mental health law a profound challenge: compulsion 
based in whole or in part on mental disability is said to be discriminatory, and thus in breach of the 
Convention.174,175 Psychiatric detention and compulsory treatment have been mainstays of 
mental health provision for more than 200 years: is their abolition possible or an idealist dream? 
How could this be accomplished within the next 10 years? Whichever path is chosen, the views of 
those who experience such treatment must be taken into account (panel 4). 
Abolition of such practices might be perceived as radical, but the psychiatric professions have (often 
after a period of resistance) adopted and promoted radical approaches—eg, the non-restraint 
movement in 19th-century England, or the move to abolish mental hospitals in Italy led by Basaglia, 
Manuali, and their colleagues in the 1960s and 1970s. The research around inpatient compulsion 
and community treatment orders raises doubt as to whether compulsion improves things for the 
patient.185–187 Other medical specialties seem to get on fine without legal compulsion; should 
psychiatry be using it, and if not, how can it be eliminated? 
Society has to see compulsion as part of a bigger picture. Programmes have to be introduced and 
adjustments made so that the full range of CRPD rights will be realised. Detention and compulsory 
treatment cannot be sensibly divorced from the provision of appropriate services, most required by 
the CRPD, that people want to use. The CRPD requires people with disabilities to be involved in all 
aspects of implementation, which might be pivotal in devising services that really do meet their 
needs. Mental health law can no longer be just about the regulation of compulsory admission and 
treatment, and the mental health legislation of the future must change to reflect this. 
Use of compulsion needs to be seen as a system failure. Some mental health-care providers have 
started to implement this view for restraint and seclusion, through the No Force First principles.188 
Expansion of this idea to compulsion generally—ie, no compulsion first—would be a good starting 
point. Some German hospitals (notably small town and rural settings, rather than urban centres) 
have almost completely abolished compulsory psychiatric treatment, with no corresponding 
increase in other types of coercion or violent behaviour.189 The long-term effects of this decision 
and whether such work can be generalised to other areas and countries is yet to be evaluated, but 
these efforts suggest that the need for legal compulsion should not be taken for granted: it might 
really be possible to do things differently. Development of alternatives to compulsion requires 
research, of which little has been done. Very little is known of how compulsion in mental health law 
is used now, let alone what can be done to avoid it. The scant evidence base makes it difficult to 
articulate what law relating to compulsion should look like in the future, if the practice of 
compulsion continues at all. 
In all of this there is a caveat: law can provide frameworks, but passing of laws does not necessarily 
change much without the political and social will to implement the law. Insufficient resources are 
part of this problem, but not the whole issue. In many countries, all psychiatric detentions are by 
judicial order after a court hearing. Although this process looks good from the outside, it is usually an 
expensive rubber-stamping exercise. Real change will come only if the people involved in the system 
engage with it and buy into its importance. 
The problem with mental health law built around risk Mental health legislation permits psychiatrists 
to decide who should be treated. These laws effectively grant psychiatrists mainly the status of 
substitute decision makers, rather than highlight their role as counsellors and mental health service 
providers. However, problems exist with development of mental health legislation based on risk.180 
As the C‘PD ĐleaƌlǇ states, ͞the eǆisteŶĐe of a disaďilitǇ shall iŶ Ŷo Đase justify a deprivation of 
liďeƌtǇ͟.ϭϳϰ 
The concept of risk became a prominent feature of mental health law and policy making in the 
ϭϵϵϬs, paƌtiĐulaƌlǇ iŶ high iŶĐoŵe ĐouŶtƌies. OŶe ƌeasoŶ foƌ this ǁas soĐietǇ͛s ďelief that ŵaŶǇ 
hazards are predictable and controllable and, therefore, policy and legislation should take into 
account all the necessary steps to avoid, or at least minimise the fallout of, a particular hazard or 
risky behaviour.190 Other reasons were that psychiatry improved its understanding of the predictive 
value of certain risk factors, alongside the growth in public anxiety that mental health services were 
not doing enough to challenge what was considered to be risky behaviour.190 
Definitions of the concept of risk are wide ranging. With regard to mental health, the term risk is 
used in the medical sense and usually refers to the probability of a person developing a mental 
disorder. However, in mental health legislation, the term is often used to describe the probability 
that a patient already having a mental disorder will harm themselves or others. On the one hand, 
some authors have argued that lawmakers across the globe believe the risks posed by patients with 
mental disorders are so high that they require specific legislation and policy.190 Thus, the notion of 
risk has evolved into an instrument of social control in modern mental health law and policy—eg, 
the Mental Health Act 2007 in England and Wales. On the other hand, some authors have claimed 
that the additional harm criteria established in Mental Health Acts of some Australian territories 
could break human rights obligations and standards by establishing a discriminatory starting point 
for mental health care of patients who are unable to consent to treatment for themselves. These 
additional harm criteria include the assessment of both the probability of patients coming to harm 
themselves and the probability of a patient causing harm to others. These criteria must be satisfied 
before patients can be treated without consent. This situation differs from no psychiatric patients, 
who, if they are unable to consent to medical treatment for themselves, will be entitled to receive 
coercive treatment if it is in their best interests.191 
  
The time has come to reconsider the development of mental health law built around risk. Risk 
assessments that place patients in high risk or low risk categories have been widely adopted by 
mental health policies, laws, and services—eg, in Australia, the UK, and the USA—in an effort to 
reduce the harms associated with mental disorders.192–194 However, most patients categorised as 
being at high risk will not engage in any harmful acts.195 Additionally, clinical decisions made on the 
basis of risk assessment divert resources away from patients classified as low risk, which in turn 
leads to reduced availability of treatments.196 
Decision making capacity and so-called best interest tests are other criteria used for the 
development of mental health law. However, both of these factors pose problems. Mental capacity 
legislation has become too broad in scope, which has led to people being subjected to treatment 
against their will. Additionally, best interests tests have been proven to be strongly attached to 
psǇĐhiatƌists͛ suďjeĐtiǀe aŶd peƌsoŶal uŶdeƌstaŶdiŶg of ǁhat is ĐoŶsidered to be best for the patient, 
ǁithout takiŶg iŶto aĐĐouŶt a patieŶt͛s pƌefeƌeŶĐes.ϭϵϳ 
The deďate aďout laǁŵakeƌs͛ attitudes to ƌisk assessŵeŶt is ĐƌuĐial to the deǀelopŵeŶt of ďoth 
mental health law and psychiatry. Some authors have argued that the emphasis on risk at the 
expense of care has made psychiatry more coercive, psychiatrists more risk averse, and has 
increased prejudice against their patients. However, limitations of risk assessment do not mean that 
emphasis on risk is not necessary at all. Psychiatrists and other physicians should be able to embrace 
the dutǇ theǇ haǀe ƌegaƌdiŶg the safetǇ of theiƌ patieŶt aŶd the patieŶt͛s faŵilǇ aŶd toǁaƌds the 
public as a whole.198,199 Psychiatrists should be able to provide optimal care according to the 
treatment needs of each patient. 
Assessment of risk of harm should not form the sole basis for law, policy, or clinical decision making. 
Mental health laws and policies must reduce the importance of risk assessment in their conception 
and redirect the focus to what patients can do, what they want to do, and how mental health 
professionals can help in the recovery process. 
The problem of coercion in mental health law 
Mental health law provides the legal authority for compulsory detention and treatment and, 
commensurate with that, contains safeguards in relation to the exercise of that authority, as well as 
setting out entitlements to services. However, it has less influence over the discretion as to when or 
how to exercise the authority to detain and treat. Coercion then becomes an important mediating 
factor as to how the legal criteria are applied and which rights are brought into play as being 
relevant. 
The law suggests a dichotomy exists: a person is detained or is not. In practice, coercion can 
determine who falls on which side of the line regarding, say, compulsory detention. Practitioners will 
be familiar with the scenario of a person refusing the offer of a voluntary admission, until faced with 
the pƌospeĐt of a foƌŵal oŶe. A patieŶt͛s legal status is Ŷot a reliable guide to how much coercion 
they felt subjected to during the admission process.200 
CoeƌĐioŶ has ďeeŶ desĐƌiďed as ͞pƌessuƌes eǆeƌted ďǇ oŶe peƌsoŶ ;oƌ oƌgaŶisatioŶͿ oŶ aŶotheƌ ǁith 
the intention of making the latter act in accordance with the wishes of the foƌŵeƌ͟.ϮϬϭ It is usuallǇ 
portrayed in a negative light, with an emphasis on the use of compulsion, or at least the threat of it. 
More recent work has viewed coercion as a hierarchy of behaviours, shading from positive forms to 
negative ones. Szmukler and Appelbaum201 have set out a spectrum from persuasion through 
interpersonal leverage, inducements, and threats to the use of compulsion. Professionals are more 
overt about the use of compulsion but need to become more honest about the use of positive forms 
of coercion. 
The work of the MacArthur Research Network on Mental Health and the Law has provided powerful 
evidence of how positive forms of coercion can have a beneficial therapeutic effect. Patients 
afforded procedural justice—namely, having a voice in the process and being treated with respect 
and in good faith—experience significantly less coercion than do those not so treated.200 This result 
can be observed in settings such as mental health tribunal hearings where the effect of decisions 
contrary to the wishes of the patient can be mitigated by following processes that promote 
procedural justice. Outside the hospital, some would argue the discussion about mandated 
community treatment needs to be re-focused from coercion to one of having a contract with the 
person concerned.202 Although advocates of compulsory community care argue it is less coercive 
than is compulsory inpatient care, the evidence of a reduction in use of mental health services or of 
improved outcomes for patients is sparse.203,204 As with compulsion in the hospital, further 
research in the community to elucidate whether and how coercion, in its various guises, has 
long-term beneficial effects such as improved engagement or levels of functioning has to be an 
important priority in the coming years. 
In the UK, the Department of Health has called on hospitals to substantially reduce their use of 
restrictive interventions and practices.205 The challenge will be to ensure that insidious forms of 
coercion are not then allowed to unwittingly dictate the life on the wards for all patients. 
Mental health legislation in the next 10 years—can one size fit all? 
WHO states that mental health legislation is essential to provide the necessary framework for 
protection of the rights of people with mental disorders because of the stigma, discrimination, and 
marginalisation they face in all societies.180 The CRPD174 has been an important landmark leading 
to developed and developing nations reviewing their legislation to safeguard the rights of those with 
mental health problems. But is a common set of principles and goals for mental health legislation for 
all countries feasible given the varied cultural, historical, political, and economic contexts? 
A huge international disparity exists in levels of resourcing of mental health services. A country with 
0·1 mental health workers per 100 000 population (eg, Vietnam) might have more difficulty 
guaranteeing access to care and resourcing human rights safeguards than would a country with 
more resources such as the UK.206 Access to mental health services is a challenge worldwide. South 
African law aims to make access to mental health services equitable.180 The USA passed the Mental 
Health Parity Act (1996) to ensure that insurance companies give equal coverage to mental and 
physical illness. Brazil has legislation to ensure access to mental health medication; Tunisia to 
medical and psychosocial care;180 and India to provide everyone with access to free mental health 
care.207 Although commendable in its aims, India͛s MeŶtal HealthĐaƌe AĐt ;ϮϬϭϳͿ ŵight ďe too 
ambitious for a country with only 0·6 mental health workers per 100 000 population.207,208 
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Much rights based legislation is drafted to protect people from abuse by the state. However, in 
many countries, such as Pakistan, China, and Indonesia, families are the main carers and might be 
struggling in the absence of community services, and using restraint and other practices that violate 
the human rights of people with mental disorders.209–211 In China, before the 2013 Mental Health 
Law, families were responsible for making treatment and admission decisions on behalf of their 
family member, not the individual themselves or the psychiatrist. Families also bear civil liability for 
theiƌ faŵilǇ ŵeŵďeƌ͛s ďehaǀiouƌ.ϮϬϵ ‘eĐeŶt legislatioŶ iŶ WesteƌŶ Austƌalia has ďeeŶ heaǀilǇ 
influenced by the increasing emphasis on the rights of families and carers as well as those of the 
individual.212 
Countries that were previously colonised by Europeans might have a legacy of institutions and 
legislation that are not well aligned with their local culture and context.213 Some countries have 
populations for whom they make special provisions as a result of past trauma, oppression, or 
mistreatment. Australian and New Zealand mental health laws have provisions for recognising and 
respecting Indigenous people and their culture (Mental Health Act 2014 Victoria and Mental Health 
Act 2014 Western Australia; New South Wales Mental Health Act 2007; Queensland Mental Health 
Act 2016; South Australia Mental Health Act 2009; and Mental Health [Compulsory Assessment and 
Treatment] Amendment Act 1999 New Zealand). Colombia passed legislation in 2011 to provide 
comprehensive support for victims of armed conflict.214 
Some cultures place less emphasis on individual human rights, and in a society where human rights 
are not a priority it can be difficult to guarantee the human rights of people with mental illness.207 
Despite the differences across countries and cultures, common challenges emerge (panel 5).215 
Mental health legislation cannot meet these challenges on its own. Poorly drafted, under resourced, 
badly implemented, or even frankly oppressive legislation can make things worse. But realistic, well 
drafted, and well implemented legislation can complement and reinforce mental health policy to 
improve the outcomes for people with mental disorders.215 
What should mental health legislation ideally cover? Historical discrimination and segregation of 
people with mental illness places them in a vulnerable situation in many societies. Legislation can 
play an important role in protecting their rights, either through standalone legislation or provisions 
protecting the rights of people with mental illness that can be incorporated into health or disability 
legislatioŶ. The C‘PDϭϳϰ has foƌĐed a tƌaŶsfoƌŵatioŶ iŶ soĐietǇ͛s ǀieǁ of disaďilitǇ aŶd people ǁith 
disability. Disability is no longer seen as a deficit in the individual that needs correction (traditional 
medical model) but as arising out of an interaction between individual impairments and social and 
environmental barriers that prevent disabled people from full and effective participation in society 
(biopsychosocial model). Laws therefore need to address effectively attitudinal and other barriers 
while simultaneously helping people to access health services to reduce their impairments. 
In the field of mental health, the adoption of the biopsychosocial model of disability also requires a 
shift from a traditional emphasis on what are considered to be the best interests of the person to an 
emphasis on respecting their will and preferences, thus removing attitudinal, social, and 
environmental barriers. Mental health legislation therefore needs to overcome the entrenched 
principle of best interests. Laws need to protect the right of people with mental illness to take 
decisions for themselves. This step forwards can be achieved through content and procedures in law 
to promote, respect, and fulfil the right of people with mental illness to exercise their will and 
preferences when receiving mental health care and treatment—eg, with advance directives, 
enduring power of attorney, support networks, personal ombudsman, personal representative, and 
representation agreements enshrined in legislation. Such tools should be used in the provision of 
mental health care and treatment. 
Another important justification for mental health legislation is to ensure access to mental health 
care. In many parts of the world, the physical health and mental health needs of people with mental 
illness are neglected with disastrous consequences—in nearly all countries where this has been 
researched, people with mental illness have 15–20 years lower life expectancy than do their peers 
without mental illness.216 This reduction in life expectancy has many causes, but disparity in 
provision of health care (and mental health care) is an important contributor,216 which can be 
addressed through legislation. 
Access to health care means provision of care in a manner that is acceptable to people with mental 
illness and their families and enables their inclusion in the community. Legal provisions can stop 
segregated services and mandate the creation of a range of mental health services that promote 
social integration and support people to live fulfilling lives in their own communities. 
For many, common medical practices such as seclusion and physical restraint are seen as cruel, 
inhumane, and degrading treatment, in much the same way as use of chai mental health service 
providers from continuing with these practices. 
Bach and Kerzner217 have outlined a practical legal model for the incorporation of the concept of 
decision making capability when providing treatment for mental illness, which can easily be 
incorporated into law in most countries. 
For too long, involuntary hospitalisation and treatment has taken centre stage in mental health 
legislation to the detriment of the rights of people with mental illness, and pitting mental health 
professionals and people with mental illness against one another. Involuntary hospitalisation is 
based on ideas of decisional in capacity and so-called best interests rather than focusing on decision 
making ability and respecting the will and preferences of people with mental illness. Laws related to 
mental illness need to move away from involuntary hospitalisation and instead focus on enabling 
decision making capability, which is a combination of the unique decision making ability of the 
individual, understanding of the will and preferences of the individual, and decision making support 
and adjustments to enable people with mental illness to make legally competent decisions. 
Conclusion 
The different authors of this section of the Commission had very different views about mental health 
legislation, with some suggesting that it does far more harm than good and should be substantially 
reduced or removed altogether, whereas others call for something akin to greater dissemination 
such that mental health is taken into account when all legislation is developed in an effort to reduce 
stigma and discrimination. The differing viewpoints probably reflect those in wider society. The aim 
of this section is to open debate about the purpose and use of mental health legislation and suggest 
possible ways forwards. 
Our majority opinion is that in the next 10 years, the primary aim of any mental health legislation 
should be to improve outcomes for people with mental disorder. Legislation should be evidence 
based, using evidence based treatment outcomes informed both by patient experience as a 
fundamental underpinning and by research aimed at the elimination of coercion and compulsion. 
There is a dearth of research on the use of coercion and compulsion. The journey to elimination 
requires a solid evidence base to justify and guide existing use of coercion and compulsion. 
Legislation should mandate for funding and resources to promote good mental health as well as 
address mental health problems. It should also take into account cultural mores and existing public 
understanding around mental illness and encourage increased advocacy for the rights of those with 
mental health issues—all factors that should, over time, shape concepts of management and care. 
In practical terms, mental health legislation should encompass the need for practitioners to show 
that they have provided an evidence based treatment package for the individual and that the 
individual has been supported to enter into a contract around how best to engage with that 
treatment package and how the provider can best deliver it. Positive coercion should be used 
routinely and more often, with tribunal panels being primarily based around agreeing treatment 
packages (which would include type of treatment, the setting for that treatment, and who provides 
the treatment), rather than whether or not the person should be in hospital. The individual would be 
part of this discussion, with reasonable adjustments made to increase the possibility of them being 
fully involved in the process. Procedures such as advocates, advanced directives, and power of 
attoƌŶeǇ ǁould all suppoƌt aŶd safeguaƌd the iŶdiǀidual͛s ƌights, ǁill, aŶd pƌefeƌeŶĐes. 
Enshrinement of an evidence based approach in law would increase the likelihood that people with 
mental health problems receive a more considered assessment plus higher quality treatment more 
likely to address their needs. The minority of individuals who have problems with violence would 
have this addressed as part of their treatment. As it became clearer where evidence around 
treatment needs was scarce, the legislation around provisions for mental health funding and funding 
of the research for mental health would come into play, requiring commissioners to fund 
appropriate services; requiring providers of mental health care to develop services that meet the 
needs of those with mental health problems; and encouraging researchers to focus their work on 
areas in need of being addressed. For example, few calls have been made for research into the 
management and treatment of violent behaviour in people with severe mental illness, despite the 
fact that this is one of the main public concerns about people with mental disorders. 
These changes would not eliminate coercion and compulsion or the undue emphasis on risk, but 
they would give increased emphasis to partnership working, negotiation, and contracting, with the 
likely additional resources (financial and manpower) that would result from governmental legislation 
(ring fencing or prioritisation of mental health funding). Psychiatrists would have to spend more of 
their time engaging people in treatment programmes and ensuring that service users are involved in 
their own care and in the decision making about their care. In the longer term, this more 
collaborative approach might mean that service users would be more likely to take more 
responsibility for their own care and be proactive about seeking treatment. Ultimately, this 
approach should result in a reduction in coercion, compulsion, and the use of hospital beds, which 
are a costly drain on resources. 
Mental health legislation should mandate training such that all health professionals have some 
mental health training and to ensure that more professionals are trained to become mental health 
practitioners in line with the known mental health needs of that jurisdiction. Similarly, legislation 
should ensure that access to good quality mental health care is available when it is needed. 
Mental health legislation should also be enshrined within equality legislation and thus cover wider 
societal issues, particularly access to housing, resources, and employment. 
All governments should include a mental health impact assessment when drafting legislation to 
ensure that it takes into account the needs of people with mental health problems and does not 
inadvertently discriminate against them. 
The ϮϬϭϳ ‘epoƌt of the UN “peĐial ‘appoƌteuƌ oŶ Health has Đalled foƌ ͞the aĐtiǀe iŶǀolǀeŵeŶt of 
the psychiatric profession and its leaders towards rights compliaŶt ŵeŶtal health poliĐies͟.Ϯϭϴ IŶ 
line with this, mental health leaders, service user organisations, and human rights specialists should 
work together in formal commissions aimed at shaping better mental health legislation. 
Within the coming decade, we could envisage regular monitoring of the recognition of the rights of 
those with mental health problems as reflected in legislation and the attitudes within treatment 
institutions and the community at large.219 This monitoring would enable different jurisdictions to 
be compared with respect to their mental health literacy—ie, how well they respect the rights of 
those with mental health problems, including the rights to care, to treatment, and, inevitably, to risk 
assessment, and, if necessary, the right to involuntary admission for treatment. We did not reach 
consensus, but in essence, mental health legislation in the next 10 years should not simply be a 
narrow piece of legislation that deals with how to manage the affairs of a person who becomes 
mentally unwell, but a wider piece of legislation that incorporates government policy about human 
rights, equality legislation, resource allocation, and individual rights, preferences, and needs. 
Part 5: Digital psychiatry—enhancing the future of mental health 
Introduction 
The digital psychiatry revolution has arrived. From tangible tools such as smartphones and virtual 
reality headsets to the underlying developments in data analytics and machine learning, a plethora 
of digital advances offers a myriad of possibilities for psychiatry. Understanding what those 
possibilities are and navigating the field towards optimal use of these new digital tools is important 
for all psychiatrists to ensure that future care offered is the best care. 
Digital psychiatry—the use of mobile and other connected digital devices to offer mental health 
services beyond traditional telepsychiatry—has rapidly emerged due to the convergence of 
technological, societal, and analytical advances. Smartphones, owing to their many data sensors, 
large screens, and various communication modalities, have emerged as early leading devices for 
digital psychiatry. They, and other devices, include the technology to collect data relevant to mental 
health, share them with the health-care system, and deliver feedback and resources based on those 
data, offering the potential of a closed loop system. However, numerous complex real world and 
societal forces continue to shape the field, as we review in this Commission. 
Widespread technology adoption has made digital psychiatry feasible 
The gloďal populatioŶ͛s ƌapid adoptioŶ of sŵaƌtphoŶes ĐoŶtiŶuesϮϮϬ ǁith estiŵates that ďǇ ϮϬϮϬ, 
80% of the adult population will own one.221 People with mental illness also increasingly own and 
use smartphones in their daily lives.222,223 However, the rapidly expanding mental health service 
gap between resource rich and resource poor countries,63 as well as the socioeconomic burden of 
mental illness, still precludes some people from accessing digital technologies such as 
smartphones.224–226 Decreasing costs and increasing availability of such technologies suggest that 
ownership and use will continue to expand. 
Interest in using smartphones for mental health care has exceeded the clinical evidence and 
knowledge base. Over 10 000 mental health apps are available for download and use,227 yet 
minimal data exist on their safety, usability, or effectiveness.228,229 Smartphones are only the first 
wave of new consumer technology applied to mental health. Wearable sensors such as fitness 
trackers,229 augmented reality glasses,230 and virtual reality headsets231 are examples of digital 
technologies entering the mental health space. Other advances that do not rely on consumer 
technology but are already projected to change health care include portable diagnostics, smart and 
implantable drug delivery mechanisms, more affordable genome sequencing, data science and 
machine learning, and digital security advances such as blockchain.232 
The widespread adoption of digital tools and their technical ability to collect data or deliver services 
related to mental health offer the potential, not yet fully realised, for digital psychiatry to have a role 
in clinical care. That potential is affected by numerous shaping forces in the real world (figure 2). 
Factors such as patient and clinician engagement, clinical validation, clinical utility, interoperability, 
scalability, and economic value will mould the hope—some might even say hype—of digital 
psychiatry into reality. What that reality might look like and how its shaping forces need to be 
balanced is the topic of this section. 
 
Figure 2: Driving forces for progress in digital psychiatry in the next 10 years Progress will be driven 
not only by new technologies, but also by numerous shaping forces. 
Towards digital phenotyping and personalised diagnosis Despite major advances in the 
understanding of the biological basis of mental disorders, clinical biomarkers remain elusive;233 the 
potential of digital phenotyping enabled through personal digital devices might offer an 
unprecedented opportunity for psychiatry.  
A vast amount of new data is now available from self-report, behavioural, physiological, 
neurological, molecular, and genetic information. These data offer an opportunity to evolve the 
nosology of mental illness away from phenomenologically derived descriptions towards more 
personalised and reliable definitions. For instance, through real time symptom surveys on devices, 
experiences can be captured while minimising retrospective recall bias.234,235 In addition to mobile 
app usage patterns,236 the sensors on these digital devices allow the capture of more objective 
behavioural data, such as global positioning system information about spatial location237 and call 
and text logs providing a window on social activity.238 Digital cameras on devices can be used to 
help to diagnose congenital disorders with dysmorphic phenotype and match patient cases to 
potential genetic syndromes. Physiological sensors on wearable devices such as fitness trackers and 
smartwatches can already capture some basic, although not necessarily precise, information related 
to heart rate and skin conductance.239 Efforts are underway to develop reliable digital sensors that 
might be able to capture mobile electroencephalographic data,240 the molecular composition of 
sweat,241 and even perform rapid genotyping.242 Clinical studies are in progress of digital pills that 
automatically monitor medication adherence243 and the near future might bring previously 
unimagined streams of digital data.244 Models to organise these data, such as the NIMH RDoC, offer 
a proposed framework (figure 3). Digital psychiatry will enable a more accessible and 
multidimensional personalised psychiatry, with opportunities to focus more on primary and 
secondary prevention.245 Within the next decade, the field might move towards identification and 
management of preclinical risk rather than only treatment of overt illness. 
The ability to collect this vast amount of digital data will probably be met with well warranted 
concern. Consider the 2014 Samaritans Radar project, a service that automatically scanned social 
ŵedia posts oŶ Tǁitteƌ foƌ Ŷegatiǀe laŶguage suĐh as ͞hate ŵǇself͟ aŶd aleƌted that peƌsoŶ͛s 
contacts that the person might need emotional support.246 A rapid national public outcry centred 
around privacy and consent quickly led to the removal of the Radar. Much more extensive and 
personal data related to mental health can now be captured in less obvious ways, raising the need 
for a public dialogue on how these data should be used in digital psychiatry. Ethical issues related to 
the use of these data remain complex and not well addressed.246 
Towards digital prevention and therapeutics 
Digital technology offers the potential to provide new models of adjunctive therapies and 
interventions that will bring treatment outside of the clinic. Telepsychiatry already possesses a 
robust evidence base247 and digital health tools offer the opportunity to make such services more 
accessible and engaging. For example, interventions such as cognitive remediation and cognitive 
behavioural therapy—effective treatments for those with severe mental illness—can now be 
delivered when and where the patient is via mobile devices, with personalised feedback delivered in 
part by automatically collected sensor data. Early evidence for this hybrid paradigm of digital 
assessment and treatment with both machine and clinician support has shown encouraging results 
with cognitive behavioural therapy,248 moving 
 
 
away from pure computer based programs to just-in-time real world interventions and personalised 
sessions.249 Encouraging research in addictions has highlighted the potential of smartphones to 
support contingency management for treatment of addictions.250 Newer technologies such as 
augmented and virtual reality offer the potential to create optimal environments and spaces for 
exposure based therapies.251 
Thus, these technologies might be means by which the concept of space in psychiatry is reversed; a 
patieŶt͛s loĐatioŶ ǁill Ŷo loŶgeƌ deteƌŵiŶe ǁhat tƌeatment they can access and instead the ideal 
environment and treatment resources will be digitally delivered to them. Many psychiatric clinics are 
based in cities in which the density of those seeking care is high, but soon it will be possible to offer 
digital services in rural or remote areas. Clinician involvement is essential for the success of digital 
interventions,252 and thus psychiatrists and psychologists in the future will probably divide their 
time between seeing patients face-to-face and supporting them through digital interventions, or 
possibly doing both in the clinic through blended therapy. 
This ŵodel of digital teĐhŶologǇ poteŶtiallǇ eŶaďles a peƌsoŶalised uŶdeƌstaŶdiŶg of aŶ iŶdiǀidual͛s 
mental illness; emerging digital tools to prevent, augment, and enhance care offer a promising 
picture of psychiatry in the coming decade. However, transformation of that potential into reality 
will require concentrated efforts to steer the development, research, and education of digital 
psychiatry towards these goals and away from possible pitfalls. The barriers listed below are both 
the opportunity and challenge for psychiatry to shape digital technology to promote improved 
patient care. They focus on shifting the focus from technology itself towards what technology can 
enable and facilitate. Neuroscience advances will probably lead to new discoveries and treatments 
for psychiatric illnesses within the next 10 years and the role of technology might be very different 
to what it is today (with current efforts mostly centred around smartphone data). However, the core 
principles of patient enjoyment, trust, partnerships with data science and machine learning, clinical 
evidence, interoperability, and clinical integration will remain important. 
Clinical considerations and training to reach the vision of digital psychiatry 
The increasing ability of technology to capture new data or offer new digital services does not 
automatically translate to clinical utility or efficacy. Technological innovations have often developed 
in isolation from advances in clinical practice; the six core considerations outlined below (figure 4) 
can help to move these two modalities closer. Although many examples feature smartphone apps, 
no smartphone platform today meets all six core considerations. Both existing and new technologies 
must seek to balance and satisfy all six if they are to have a clinical role in the future of digital 
psychiatry. Of utmost importance, ensuring that care and user needs lead technology development, 
rather than vice versa, will result in viable and effective—rather than disruptive and short lived—
advances. 
Creating engagement through stronger patient partnerships Shaping of digital technology to best 
benefit mental health care requires increased involvement from both patients and clinicians. 
Focusing here on patients, these digital tools must successfully meet the needs of those who use 
them. For example, numerous mood tracking apps are available, but for patients with depression 
many apps have proven difficult with regard to entry and retrieval of data.253 Patients have also 
Ŷoted that todaǇ͛s apps do Ŷot offeƌ eŶough eŵotioŶal suppoƌt, distƌaĐt fƌoŵ ƌeal life ĐhalleŶges, 
might lead to care avoidance, and cause misrepresentation of symptoms.254 Many are simply not 
enjoyable to use. It is hardly surprising that smartphone apps for mental health struggle with poor 
adherence.255–257 Most individuals might never use a mental health app after downloading.255 
Although digital mental health might evolve past smartphone apps, the requirement for technology 
to ŵeet useƌs͛ Ŷeeds ǁill ƌeŵaiŶ ĐoŶstaŶt. IŶǀolǀeŵeŶt of patieŶts iŶ all phases of the desigŶ, 
research, and implementation of these technologies will be crucial for success. 
Of course, technology alone cannot solve engagement. Clinician involvement with the technology is 
a key factor in increasing user satisfaction and engage-ment,258,259 but psychiatry has not yet 
established models or best practices for how best to engage digitally with patients. The same digital 
divide in terms of confidence and understanding of technologies seen in some portions of the 
mental health patient community might also be present among mental health professionals. Many 
clinicians had practised for years before smartphones were invented, let alone applied to mental 
health, leading to an often unrecognised need to educate colleagues about digital tools. The number 
of digital devices, their ability to generate constant data, and the novel nature of these data present 
a challenge for the field. Many psychiatrists remain justly concerned about the role of digital 
technology in the doctor–patient relationship and will probably remain reluctant to engage until 
stronger safety, utility, and efficacy evidence is established.259–261 Engagement with psychiatrists 
also requires their involvement in the development of these technologies. How to ensure that both 
patient and psychiatrist voices are heard effectively is a topic for further research, but it might be 
the most important, and currently underappreciated, step needed for digital psychiatry to advance. 
These two voices will also have to navigate the doctor–patient relationship in an increasingly digital 
era where clinicians and patients each have access to more data and information. Digital psychiatry 
does not mean that clinicians release all treatment responsibility to service users or that service 
users ignore clinical advice because of access to new tools. Rather, a balancing of power between 
clinicians and service users is necessary, although the dynamic nature of technology can make that 
equilibrium difficult to find. Further research in this space will be key for the success of digital 
psychiatry. 
 
Another often overlooked aspect of engagement is that although increasingly many people have 
access to digital devices such as computers and smartphones,222,262 some individuals still do not. 
The monthly costs and fees associated with smartphones and their use might still be too high for 
many to have reliable smartphone service,263 and people in resource poor countries or of low 
socioeconomic status probably do not have the same access opportunities as do their richer 
counterparts.264 However, technology costs continue to decrease, meaning both feasibility and cost 
effectiveness of digital psychiatry remain a ŵoǀiŶg taƌget. AssessŵeŶt of a patieŶt͛s digital 
technology access, as well as comfort and fluency, will probably become part of routine screening, 
with specialised education or peer support programmes developed to ensure that all can access 
these tools. 
Building digital trust and transparency 
The role of digital psychiatry in the next 10 years will also depend on trust. Even with advanced 
technology, the foundation of health care and especially psychiatry remains based on trust and a 
strong doctor–patient relationship. If patients are not comfortable disclosing sensitive information, 
the foundation of digital psychiatry will be fatally flawed. Patients need to feel confident that in 
sharing their psychiatric history, their experiences and private information will be respected. 
Likewise, patients need to be aware of the scope of data that can be collected about them via digital 
devices, especially in the case of passive data, and they must understand why and how it will be 
used. Just as psychiatrists today educate patients on risks and benefits of medications and 
treatments, in the future they will need to be able to discuss risks and benefits of digital monitoring 
or interventions, and help patients to make informed decisions. 
At present, serious concerns remain regarding the privacy, transparency, and confidentiality of 
digital health tools. The current culture where smartphone app privacy policies are often 
non-existent265 or, when present, obfuscate how patient data are handled and shared266 is not 
compatible with the goal of widespread clinical use. Even in 2016, governing bodies such as the US 
Department of Health and Human Services have noted pitfalls and concerns related to the little 
public trust associated with the app marketplace,267 and NHS England closed its app store in 2016 
for the same reasons. Although new digital technologies such as block chain will help to secure 
digital health information against malicious hacking, trust building is more than a technical problem 
and the field will need to focus on the ethics of digital psychiatry.250,268–270 Existing digital tools 
mainly monitor symptoms or offer present guided therapies, but growing evidence suggests that 
these digital tools work best when coupled with human support.252,258 In the near future, artificial 
intelligence, automated decision making, and individualised therapies will probably become closer to 
reality, but it is unclear whether they can rival the increased engagement and efficacy noted from 
human supported use of technology. Efforts to create empathetic technologies for mental health are 
underway.271 Psychiatrists will need to become familiar with these many ethical issues that will 
arise. A good start is to look for a privacy policy for a device or application and learn what 
protections have been put in place. The American Psychiatric Association offers a useful free 
resource to help to evaluate apps on its website. 
Data science and methods 
With digital psychiatry studies assessing real time passive data from individuals and existing 
programs such as electronic medical records collecting or generating big data (data of high velocity, 
high volume, and high variety), the analytical methods to process these data have become 
increasingly complex. The analytical methods for processing big data are also challenged by the 
complexity of clinical psychiatric data. For example, an overlap exists between different diagnoses of 
helping to predict response to anti-depressants,277 analyse speech for risk of conversion to 
psychosis,278 and even augment risk assessment.279 
In the next decade, we expect the development of a branch of psychiatry dedicated to these digital 
tools in the same way that some psychiatrists today specialise in interventions such as transcranial 
magnetic stimulation or electroconvulsive therapy. Clinical informatics is already a subspecialty and 
more training opportunities will probably arise. Partnerships with data science will become more 
common and it is not unforeseeable that data analysts will be part of the clinical team in the near 
future. 
Building of the evidence base, standards, and creation of best practices 
Although pilot data exist supporting the feasibility and acceptability of digital psychiatry tools such 
as smartphone apps across nearly all conditions,280 clinical data on tools such as smartwatches, 
augmented reality, virtual reality, artificial intelligence chat bots, and digital therapeutics remain 
scarce.281 Large-scale digital psychiatry studies on schizophrenia and depression282,283 have 
provided acceptability and feasibility results but no efficacy data. Even simple claims, such as fitness 
trackers being able to accurately measure heart rate, have in some cases proven nearly seriously 
wrong and led to legal disputes regarding false claims and misrepresentation of technology.284 As 
Thoŵas KuhŶϮϴϱ ǁƌites iŶ The “tƌuĐtuƌe of “ĐieŶtifiĐ ‘eǀolutioŶs, ͞the suĐĐess of the paƌadigŵ...is 
at the staƌt laƌgelǇ a pƌoŵise of suĐĐess...sĐieŶĐe ĐoŶsists iŶ the aĐtualizatioŶ of that pƌoŵise͟. 
Actualisation of the promise of digital psychiatry is thus another challenge facing the field. Today, 
even the simplest questions, such as which patients will benefit most from digital interventions, at 
what dose, with how much human support, and for how long, are still largely unanswered. 
Mechanisms of change through digital technologies are also largely unknown. Initial hopes that a 
simple digital translation of validated clinical scales or effective in person treatments would prove 
valid and effective have given way to more fundamental research to create an evidence base for 
digital psychiatry. 
As research and understanding of digital psychiatry expands, carefully crafted standards will be 
necessary to help to guide development without hampering innovation. Few clear or well adopted 
commercial or medical standards have led to the promulgation of many low quality and even 
dangerous apps on the commercial marketplaces.227 The US Federal Trade Commission recently 
targeted false claims by makers of so called brain training apps.286 The difficulty in finding a safe 
and effective app is well known to anyone who has searched for the word depression in these app 
marketplaces and been confronted with hundreds of apps making increasingly bold claims. Early 
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conventional data mining algorithms are not well suited to processing data with such vague labels. 
The NIMH RDoC model might offer a useful framework for understanding how different types of 
psychiatry data (eg, self-reported symptoms, behaviours, physiology) can be collected from digital 
devices and organised in a manner to facilitate meaningful analysis.272 Integration and processing 
of multimodal data from digital tech-nologies also present substantial challenges.273–275 Big data 
are a supplement to, not a substitute for, traditional data collection and analysis in psychiatry. Use of 
big data does not mean that the basic principles of study design, data collection, and data analysis 
can be ignored. To obtain robust results, findings must be replicated in independent populations to 
examine their generalisability.244 
Neuroimaging modalities such as CT and MRI scans have advanced interest and understanding in 
fields such as neuroradiology and neuropsychiatry in which psychiatrists, neurologists, physicists, 
and data scientists work together to transform brain imaging into clinically relevant information. 
Similar efforts will be necessary with smartphone data and digital phenotyping. The quantity and 
complexity of data from smartphones is beyond that of neuroimaging, where all setting and 
measurement parameters are carefully controlled in a clinical or hospital setting. Smartphones today 
can easily generate over 1 million data points per patient per day. The volume of data, let alone its 
complexity, is expected to expand as new devices are introduced. Considering the amount of data 
generated from electronic health records, pharmacy records, genetic testing, and neurodiagnostics 
such as electro-encephalography, the field will clearly need new methods and tools to transform 
data into clinical information. Big data are already affecting psychiatry,276 technological change in 
digital devices and data processing capability. Will the availability of preclinical digital phenotype 
signatures, including whole genome scans from infancy, lead to prevention of many psychiatric 
disorders? Will digital devices, combined with fully elucidated connectomics of brain wiring, and 
sophisticated neuromodulation, create a synergy that advances the field in directions currently not 
even realised? Although all of these developments are within the realm of possibility, we predict 
that such changes will probably not happen within the next 10 years, given the enormous ethical, 
practical integration, fiscal, and technological challenges. Social media and Facebook have existed 
for over a decade, but have not transformed the daily clinical practice of psychiatry.299 In the next 
10 years, the field will see change. We believe that digital devices will lead to reduced need for office 
visits, increase access to care for a larger number of people, and facilitate seamless integration of 
care. Progress will occur; however, it might not be new digital devices but rather development of 
systems and means to integrate such devices into new models of care that will enable population 
level change. 
This favourable scenario can be made possible only via expanded partnerships with patients and 
collaborations with data scientists. Novel research methods, trans-parency standards, clinical 
evidence, and care delivery models must be created for the field to utilise digital advances. 
Regardless of what technology can do, it will have a suboptimal effect in psychiatry unless it is 
developed in a coherent manner that meets the needs of all stakeholders and addresses the core 
considerations outlined above. From simple innovations such as improved battery life for 
smartphones to novel analytical models, the influence of digital technologies will interact with 
advances in neuroscience and genetics to create a plethora of potentials. Thus, looking at what 
digital psychiatry will be in the next 10 years is not so much about predicting the future but a start to 
building towards that future here and now in 2017. 
Part 6: Training the psychiatrist of the future 
Introduction 
The rapid pace of scientific advances combined with evolving models of health-care delivery have 
broad implications for how to train psychiatrists for the future. Medical educators and psychiatry 
training programmes must ensure that the graduating workforce is not only armed with the latest 
medical knowledge and clinical skills but prepared to adapt to a changing landscape. Because new 
evidence based practices often take 15–20 years to become standard of care,300 training 
programmes must often forge ahead into uncharted territory and assist in the process of 
implementation and dissemination. As a result, training in psychiatry has an important role to play in 
setting standards for care and shaping the future of the field. 
Priorities for training in psychiatry 
In the setting of numerous advances, several training priorities will be essential for the field of 
psychiatry in the coming years. To meet the growing need for mental health services, training in 
psychiatry will need to focus on new models for health-care delivery and, as a consequence, will 
need to expand training in team management, leadership, and collaborative care.301,302 At the 
same time, training of psychiatrists in strategies to integrate and harness the power of information 
technology will be essential. Fostering a culture of lifelong learning and provision of skills training in 
quality improvement strategies will perhaps be the most important step to prepare psychiatrists for 
a rapidly evolving field. In addition, as research expands the understanding of the biological 
underpinnings of psychiatric illnesses, integration of a contemporary neuroscience perspective 
alongside the other strong traditions of psychotherapy and social psychiatry will become increasingly 
important.303 
New models for health-care delivery 
Although mental illness and substance use disorders are the leading cause of years lived with 
disability,304 access to high quality mental health care is far from universal. With only nine mental 
health providers per 100 000 people worldwide,305 access to care is further complicated by 
disparities, stigma, and insufficient resources. Where resources do exist, the availability of mental 
health services is restricted by unsustainable, escalating costs and fragmented, siloed delivery 
models. Given these challenges, most patients with mental illness around the globe are not seen by 
ŵeŶtal health speĐialists ďut ƌatheƌ iŶ pƌiŵaƌǇ Đaƌe settiŶgs, ŵakiŶg pƌiŵaƌǇ Đaƌe the ͞de faĐto 
ŵeŶtal health sǇsteŵ͟.ϯϬϲ UŶfoƌtunately, in these settings, mental health problems often go 
undetected, and when recognised they are frequently undertreated.306 
To address these issues, new efforts to extend and integrate mental health services within primary 
care settings have emerged. These include collaborative care models whereby psychiatrists work 
with primary care doctors and behavioural health-care managers to address the mental health needs 
within a specific patient population. Task shifting and stepped care approaches have also been used 
in LMICs. In these systems, non-specialists and community health workers are trained and 
supervised to provide some basic mental health care with referrals to more specialised care when 
needed.24 Telepsychiatry has also been identified as an effective approach to expand access to 
mental health to remote and underserved areas.307 Well-resourced countries have also seen a push 
towards early intervention as a cost effective measure. 
At the same time, patients with chronic psychiatric conditions might be well connected to 
behavioural health settings (long term residential care settings, or outpatient psychiatric clinics and 
day treatment centres) and yet have insufficient access to general primary medical care. This 
situation is particularly concerning because many general health conditions are more prevalent 
among patients with severe mental illness.308 A host of factors including lifestyle choices, side 
effects of psychiatric medications, and disparities in both the quality and use of health care among 
patients with mental illness are likely contributors.308 In response, proposed solutions have 
included the embedding of primary care providers in behavioural health-care settings and extension 
of the scope of practices of psychiatrists to include management of general medical problems in 
consultation with primary care physicians.309,310 
All of these approaches have profound implications for medical training. Perhaps first and foremost 
is the need to reconsider what training in psychiatry general practitioners should have. WHO has 
estimated that, worldwide, less than 4% of training for general physicians and nurses is dedicated to 
mental health.311 An increase in basic exposure to psychiatry within medical school and within 
specialised training of other primary care providers will be crucial to meet the widespread need for 
basic mental health care. In recognition of the growing importance of addressing mental health 
needs among all patients, the Royal College of Psychiatrists has expanded training in psychiatry 
within the 2 foundation years all doctors must do before moving onto specialty training, with half of 
all doctors participating in at least 4 months of postgraduate psychiatry training.312 
For psychiatrists, focused education in the management of those general health conditions most 
common within psychiatric patient populations (eg, obesity, diabetes, hypertension) should be 
emphasised within existing training programmes. For both mental and general health conditions, all 
providers will need to have training in general screening and preventive strategies.313 This training 
includes learning how to counsel patients about their lifestyle choices—particularly surrounding 
issues of smoking, exercise, and diet—and motivate change.301 
To adapt to new health-care delivery models, training in team based approaches and population 
based care will be essential. Psychiatrists will need to expand their focus from just the individual 
patient and provision of direct care to also overseeing the treatment and outcomes of a larger 
patient cohort through registries and collaborations with emerging professional groups and other 
health providers (such as nurse practitioners and physicians associates).301 As such, training in 
measurement based care and the use of standardised metrics to track outcomes will be important, 
as well as the use of information technology to manage large sets of data.33,301 Within these new 
roles, psychiatrists will also need to develop specific leadership and management skills to train and 
oversee a diverse cohort of providers while staying attuned to the fidelity and quality of the 
work.314 Psychiatrists will also need to become well versed in the use of technology to deliver care 
(see Part 5: Digital psychiatry). With telepsychiatry gaining popularity, psychiatrists will need to 
comply with professional practice standards and understand the unique issues regarding privacy and 
confidentiality in using these types of services.315 Psychiatrists need to learn how to work with a 
diverse set of providers and partners working at other sites. They will also need to learn how to build 
an alliance and conduct an efficient interview using technology.307 In addition to telepsychiatry, 
psychiatrists will need to familiarise themselves with an emerging market of online tools that 
patients can use to track symptoms or to participate in self directed therapy (such as cognitive 
behavioural therapy).316,317 Learning when and how to effectively integrate the evolving role of 
technology into clinical practice will be increasingly important. 
Quality improvement and sustainable health care 
In high income countries, it typically takes 15–20 years for knowledge generated by randomised 
controlled trials to be incorporated into standard care.300 This gap is plausibly even larger in LMICs, 
where fewer resources are available and infrastructure is less developed. To address this gap, 
growing emphasis has been placed on teaching of quality improvement and patient safety across 
disciplines.313,318 Clearly, psychiatrists need to do more than keep up to date with the literature; 
they must be trained in the skills necessary to adopt new evidence based practices. Development of 
skills in quality improvement supports lifelong learning and emphasises that psychiatry training is 
not limited to a siŶgle tiŵefƌaŵe ďut ƌatheƌ a loŶgitudiŶal Đouƌse that ĐoŶtiŶues oǀeƌ a peƌsoŶ͛s 
lifetime. 
Adapted from the manufacturing and airline industries, quality improvement is a systematic 
approach to goal setting, identification and testing of strategies intended to help to reach those 
goals, and measurement of performance or outcomes. Through iterative cycles of change, improved 
outcomes can be measured at the level of individual providers, hospital systems or care networks, 
and ultimately (and ideally) patients. Such improvements then inform future best practices for 
dissemination. 
Along with developing skills in quality improvement, psychiatrists will need to learn how to track and 
report on quality measures within the context of value based care.319 Although many systems are 
pushing for concrete quality measures, so called recovery oriented care is redefining how the 
health-care community thinks about treatment goals, moving from simply the management of 
symptoms to the incorporation of patient goals for a meaningful and satisfying life, which might not 
translate easily into tangible, objective measures.320 
Given the unsustainable cost of health care, psychiatrists will also need to develop a focus on 
ƌesouƌĐe ŵaŶageŵeŶt, oƌ hoǁ to pƌoǀide ͞the ŵost effeĐtiǀe, fair and sustainable use of finite 
ƌesouƌĐes͟.ϯϮϭ A ŵoǀeŵeŶt foƌ sustaiŶaďle health Đaƌe has foĐused atteŶtioŶ toǁaƌds disease 
prevention, patient empowerment and self care, lean service delivery, and the use of low carbon 
technologies in health care.321 In addition to developing skills in these areas, psychiatrists must 
continue to develop skills in mental health advocacy to shape and inform government policies in a 
way that respects the rights of individuals with mental illness while reducing stigma, discrimination, 
and barriers to treatment.322 
Integration of a neuroscience perspective 
Across medical specialties the focus for the past several centuries has been on understanding the 
physiology of the organs of specialisation. Because mental disorders emerge from disruptions in 
Ŷoƌŵal ďƌaiŶ fuŶĐtioŶ, the ͞psǇĐhiatƌist of the futuƌe ǁill Ŷeed to ďe a ďƌaiŶ sĐieŶtist͟.ϯϮϯ AŶ 
understanding of normal anatomy and physiology of the brain as it relates to complex behaviours, 
thoughts, and emotions will be essential to understand the pathophysiology of the illnesses 
psychiatrists treat. 
As the brain is several orders of magnitude more complex than any other organ in the body, 
psychiatry has faced greater challenges in the development of sophisticated biological explanations 
for those disorders relevant to the field. However, with new techniques, the understanding of brain 
function (and dysfunction) has expanded across multiple levels from genetics and epigenetics to 
neurotransmitters, second messenger systems, and neural circuitry.324 Neurobiology is rapidly 
expanding the understanding of psychiatric illnesses, such as depression, anxiety, and psychosis. 
Appreciation of the neuroscience underlying mental illness has now extended far beyond the 
caricature of a so called ĐheŵiĐal iŵďalaŶĐe. AdditioŶallǇ, psǇĐhodǇŶaŵiĐ ĐoŶĐepts suĐh as people͛s 
sense of self and identity, unconscious motivations, and defences and drives are increasingly 
understood in terms of cognitive neuroscience.323 
With an increased emphasis on the underlying pathophysiology, future advances in neuroscience are 
likely to transform the way psychiatric illnesses are diagnosed and treated. Current initiatives such as 
the NIMH RDoC31 in the USA and the European Roadmap for Mental Health Research are redefining 
the way the mental health-care community conceptualises psychiatric illness, from existing 
classification systems with clusters of heterogeneous symptoms to coherent cognitive, behavioural, 
and biological dimensions that cut across diagnostic domains.325 Ideally, this approach will enhance 
understanding of the biological underpinnings of specific symptoms. In turn, psychiatrists might 
eventually be able to tailor treatments to individual patients on the basis of their own unique 
presentation and biological data, in an ideal world of precision or personalised medicine. For 
example, genetic data or other biological markers might ultimately guide treatment decisions so that 
psychiatrists can select the best treatment option for each individual patient, maximising the 
likelihood of therapeutic efficacy while minimising the risk of drug toxicity.326 Furthermore, the 
issue of prevention in psychiatry might finally be within reach, in addition to the focus on diagnosis 
and treatment. 
For future scientific advances to reach their full potential and move beyond the laboratory to the 
bedside, all psychiatrists will need to have a strong foundation in neuroscience and genetics. 
Training in clinical neurology, as takes places routinely in some countries, would go some way to 
facilitate this. Psychiatrists will need the skill set to be able to understand the scientific literature and 
the implications of new research findings for their patients. They will need to understand when to 
order new tests and how to interpret them. In addition, psychiatrists will need to be able to 
effectively translate and communicate these findings to their patients in a meaningful way. For 
example, as the commercial availability of genetic testing expands, psychiatrists will increasingly 
need to be able to communicate with patients about the current benefits and limitations of this type 
of information as it applies to the field of psychiatry.327 
Considerable efforts to expand neuroscience training within psychiatry are already underway in both 
the UK and the USA. The Royal College of Psychiatrists has received funding from the Gatsby 
Foundation and Wellcome Trust to substantially expand, modernise, and implement the clinical 
neuroscience aspect of its postgraduate curricula. The National Neuroscience Curriculum Initiative, 
suppoƌted ďǇ the NIMH, aiŵs to ͞Đƌeate, pilot, aŶd disseŵiŶate a ĐoŵpƌeheŶsiǀe set of shaƌed 
resources...that will help to train psychiatrists to integrate a modern neuroscience perspective into 
every facet of their clinical work͟.ϯϮϴ 
Although many findings in neuroscience have not yet translated into new treatments, science can no 
longer be claimed to be clinically irrelevant for patients. At a minimum, modern scientific 
explanations offer patients an opportunity to understand their psychiatric symptoms in the context 
of a medical paradigm, which might be particularly therapeutic in the destigmatisation of mental 
illness.323 
Social and cultural psychiatry and psychotherapy 
As understanding of neuroscience has advanced, it has become increasingly clear that gene 
expression is shaped by experience and that the expression of mental illness often emerges from an 
interplay between underlying neurobiology and environmental triggers.329 With this in mind, 
psychiatry will need to continue to eŵphasise the iŵpoƌtaŶĐe of the patieŶt͛s iŶdiǀidual stoƌǇ aŶd 
the social context and experience that they bring with them. 
Social, religious, and cultural differences are widely recognised to influence how mental illness is 
defined, understood, and treated. With changing demographics among patient populations and the 
recent migration and refugee crisis seen throughout the world, training in cultural psychiatry 
remains particularly relevant.330 Expansion of access to care to distant sites through technology 
(such as telepsychiatry) will also require an appreciation and respect for local cultures, traditions, 
and belief systems.307 
The use of evidence-based non-pharmacological treatments (such as psychoeducation and 
psychotherapy) will remain essential tools for treatment of mental illness within psychiatry. The 
phǇsiĐiaŶ͛s aďilitǇ to foƌŵ eŵpathiĐ, healiŶg ƌelatioŶships ǁith patieŶts ǁill ƌeŵaiŶ a ĐoƌŶeƌstoŶe iŶ 
the practice of psychiatry. Although the field of psychiatry has historically labelled psycho 
pharmacology as biological treatments and psychotherapy as psycho logical treatments, research 
has shown that effective treatments, whether psychotherapy or medication, alter core brain 
regions331,332 and as such can all be considered biological treatments. As described by Insel and 
QuiƌioŶ,ϯϮϯ ͞Just as ǁe ƌeĐogŶize the Ŷeed foƌ ƌehaďilitatioŶ folloǁiŶg the aĐute Đaƌe foƌ aŶǇ seƌious 
injury or medical illness, ideally the psychiatrist will increasingly be part of a team that provides 
culturally valid, psychosocial rehabilitation along with medications to help those with mental 
disoƌdeƌs to ƌeĐoǀeƌ aŶd ƌetuƌŶ to a pƌoduĐtiǀe aŶd satisfǇiŶg life.͟ 
Given the training demands, psychiatrists cannot realistically be expected to become proficient in 
effectively delivering all the different types of psychotherapies available. However, psychiatrists will 
still need to know how to effectively engage and motivate patients and employ psychologically 
informed approaches for problem solving and safety planning. Although training in unique therapy 
modalities such as cognitive behavioural therapy or psychodynamic psychotherapy might be ideal, 
psychotherapy training in the future might focus more on common factors that cut across different 
therapies, such as the therapeutic alliance and empathic listening.333 In addition, future research 
will probably lead to an increased understanding of how psychotherapies work and, more 
specifically, how different psychotherapy modalities might affect brain circuits in different 
conditions. Psychotherapy education might similarly evolve to focus on core elements drawn from a 
host of different therapeutic approaches based upon their mechanism of action. In translating these 
advances to practice, specific psychotherapy techniques might be taught and used a la carte and 
tailoƌed to the patieŶt͛s uŶiƋue pƌeseŶtatioŶ aŶd disease pƌoĐess.ϯϯϰ 
Physician wellbeing 
A greater emphasis on physician wellbeing is needed within all disciplines of medicine, including 
psychiatry. The inherent demands of the career, along with increasing calls to do more with less, 
creates a high risk for burnout. Several studies have estimated burnout among residents in training 
to be more than 50%.335 Burnout has been attributed to long work hours, financial difficulties, and 
fatigue, and is associated with a decline in performance, medical errors, and problems with 
professionalism.335 Improvements in working conditions need to occur simultaneously with training 
in strategies that enhance resilience. Training programmes and employers are responsible for the 
development of cultures that support employees and promote a positive educational environment. 
 
Approaches for training: not just what but how? 
Preparation for the future of psychiatry requires consideration of not just what to teach 
psychiatrists, but how to teach it. An expanding body of literature on adult learning is moving the 
field of medical education away from lecture based methods and towards more interactive, skills 
based methods including simulation. Leveraging of technology through online learning platforms is 
not only helping to standardise training approaches but also enhancing dissemination and enabling 
resource sharing and new opportunities for collaborations across programmes—both nationally and 
internationally. As new models of health care emerge, interdisciplinary and interprofessional training 
approaches will become increasingly important. 
Active, adult-learning approaches 
Medical education has historically consisted of classroom based lectures augmented with clinical 
training experiences. However, lectures are particularly ineffective at transmitting information: after 
a lecture, attendees only remember about 20% of the content.336 In addition, the ability to recall 
facts is not enough to practise medicine effectively—the complexity of medicine requires that 
students be able to understand, synthesise, and apply the information learned to clinical practice. 
Evidence suggests that participants are more likely to learn when they are actively involved in the 
manipulation of information as opposed to being passive recipients. In response, medical educators 
have tapped into adult learning theory and are transforming the classroom into interactive learning 
sessions. Training in psychiatry should be based on principles of adult learning. Malcolm Knowles, a 
renowned adult educator, described how adult learners prefer learning to be self directed, 
experiential, relevant to the performance of their roles, and problem centred rather than subject 
centred.337 
As seen across health-care disciplines, training the psychiatrist of the future will probably involve 
approaches referred to as blended learning and the inverted or flipped classroom (figure 5). In these 
approaches, learners typically participate in a self directed learning phase before coming to the 
classroom. This initial phase might include reading an article or watching a brief online video. The 
classroom is then reserved for more interactive learning approaches whereby trainees assimilate 
and apply what they have learned to reinforce learning. Such interactive learning might include 
role-play exercises or group discussion, among other techniques. 
Another approach gaining popularity within medical education is problem based learning. In this 
approach, trainees reinforce their learning by working together to solve an open ended problem. 
Through problem based learning, trainees not only learn how to apply information they already 
know, but also learn to identify what additional information they need to know and how to access 
this information so that they can solve the problem. This approach also teaches collaboration and 
teamwork. The continuing expansion of medical knowledge makes teaching of all the content 
increasingly difficult, thus making the skill set developed by problem based learning all the more 
important for future psychiatrists.  
Shared resources for training 
Historically, medical programmes (including psychiatry training programmes) have each worked in 
isolation to develop and implement training curricula. With the expansion of medical knowledge, 
particularly neuro-science, it is becoming increasingly difficult for each programme to independently 
develop and cover all of the relevant material we hope future psychiatrists will know. In response, 
collaborations such as the National Neuroscience Curriculum Initiative are extending across 
programmes to develop shared open resources for teaching.303 Additional examples of open access 
resources for medical education include FOAM (Free Open Access Meducation), SlideShare, 
MedEdPORTAL, Khan Academy, and TED (Technology, Education and Design) Talks. 
Advances in online platforms have also allowed for widespread dissemination of teaching through 
massive open online courses (MOOCs). MOOCs provide a variety of free online resources including 
lectures, videos, virtual patients, and quizzes on a variety of medical topics, and are expanding the 
conceptualisation of teaching from a classroom with a few students to an online community with 
potentially over 100 000 participants. Through webinars, attendees can join in from remote sites and 
post questions in real time, providing another mechanism for sharing of expertise across 
programmes.338 
These open access materials might be particularly relevant for smaller training programmes with few 
local resources and to expand higher education opportunities to LMICs. In a way, these types of 
resources might also provide a mechanism for the creation of more uniform teaching standards 
around the globe. 
Integrated training 
As much as psychiatry training programmes have historically worked in isolation from one another, 
they have also been disconnected from other disciplines and professions. As health-care models 
move towards more integrated care, psychiatrists will need to train in tandem with other teams of 
professionals including nurses, social workers, and internal medicine doctors. Interprofessional 
training can be particularly helpful to prepare physicians to work within a team and communicate 
with other providers.339 Students participating in interprofessional educational opportunities have 
ƌepoƌted aŶ iŵpƌoǀed uŶdeƌstaŶdiŶg of eaĐh teaŵ ŵeŵďeƌ͛s pƌofessioŶal ƌole aŶd ŵoƌe opeŶ 
communication and collaboration.340 
In addition to interprofessional training, growing emphasis has been placed on the role of the 
patient within medical education. Incorporation of patients (and carers) as educators within medical 
training is particularly important to teach the principles of recovery oriented care and combat 
negative stereotypes of patients with mental illness and substance use disorders.341 
Uniform standards and outcome measures 
Disciplines across medical education have seen a growing movement away from subjective outcome 
measures to more specific, objective performance measures. Within the USA, the Psychiatry 
Milestone Project has established an evaluation system to track trainee development across a series 
of observable behaviours.342 The programme recognises the developmental trajectory of learning, 
creates uniform standards, and allows programmes to track individual learner strengths and areas 
for improvement. In addition to the milestones, medical education is also defining outcome 
measures through entrustable professional activities (EPAs). Competencies are defined in terms of 
knowledge, skills, and attitudes, but they are also often vague and difficult to measure. By contrast, 
EPAs are clearly defined tasks that a trainee should eventually be entrusted to perform 
independently and without supervision. They often draw together several competencies and 
ŵilestoŶes.ϯϰϯ Foƌ eǆaŵple, aŶ EPA iŶ psǇĐhiatƌǇ ŵight ďe that the ƌesideŶt is aďle to ŵaŶage ͞the 
polǇphaƌŵaĐǇ of tƌeatŵeŶt ƌesistaŶt patieŶts͟.ϯϰϯ IŶ ďeiŶg aďle to deŵoŶstƌate this skill, the 
resident must also be able to demonstrate competency in medical knowledge, patient care, and 
practice based learning and improvement.343 
Educational activities and evaluation strategies are also becoming more uniform through 
standardised patients, simulation, and virtual patients. Although multiple choice examinations 
continue to have a role in assessment of medical knowledge, there is growing recognition that this 
knowledge does not necessarily translate to the skills necessary to develop an alliance with a 
patient, conduct an efficient and thorough patient interview, and synthesise an appropriate 
formulation and treatment plan. Objective structured clinical examinations (OSCEs) are becoming 
more commonplace along with the use of standardised patients. The clinical skills evaluation 
required by the American Board of Psychiatry and Neurology for board eligibility requires that 
residents in training pass several observed patient interviews and presentations with a board 
certified psychiatrist using a structured, standardised rating form. The Royal College of Psychiatrists 
requires postgraduate psychiatric trainees to pass the Clinical Assessment of Skills and Competencies 
examination—a 16-station OSCE that tests expertise in assessment, treatment, communication, and 
clinical knowledge—before they enter higher training. 
Similar to expectations for practising psychiatrists, trainees will probably also be evaluated on the 
basis of specific quality performance indicators and compliance with evidence based standards. In 
addition, patient feedback will become increasingly important information for evaluation of learners, 
along with input from other members of the team (or 360° evaluations). 
Although training standards are becoming more uniform for those programmes that fall under 
specific accreditation systems, psychiatry training remains variable around the world in terms of the 
length of training, specific training requirements, and how competency is defined and measured. 
Challenges for future psychiatry include striking a balance between standardised training and 
meeting the needs and realities of each local context. Regardless, worldwide shortages in psychiatry 
make recruitment to the field a key issue in the future of psychiatry training. 
Continuing education 
To train the psychiatrist of the future, the education mission must be recognised as not only being 
important for new generations of psychiatrists entering the field but also for practising psychiatrists 
who need to keep up to date with the latest advances. Training programmes must make sure that 
clinicians and supervisors teaching trainees are informed about new evidence based practices. As 
such, training programmes are often the vanguard pushing the field forwards. As described here, the 
task is not only to keep the field abreast of the latest developments in psychiatry but also within 
medical education. As such, teaching trainees how to teach will also be key to sustaining advances in 
the field. 
Although medical education efforts continue to focus predominately on medical knowledge, 
individual accreditation and certification programmes (such as the American Board of Psychiatry and 
Neurology and the Royal College of Psychiatrists) now recognise the important role of quality 
improvement and systematic evaluation of practice habits in conjunction with new standards. In 
addition, increasing emphasis is placed on incorporation of peer and patient feedback into practice. 
A focus on enhancing skills for learning and for the adoption of new evidence based practices will 
have greater long term benefits than would an exclusive focus on existing medical knowledge and 
practices that are likely to evolve over time. 
Conclusion 
Training in psychiatry requires not only communication of existing knowledge to new learners, but 
also taking stock of where the field is headed and preparing learners for new developments that lie 
on the horizon. As the amount of content learners need to know expands, training programmes in 
psychiatry will increasingly need to leverage shared resources in addition to maintaining focus on 
the process of teaching and how best to engage learners. These issues are all pivotal as society 
moves to an age where knowledge of facts is less important than how new knowledge is accessed 
and deployed—ie, in an integrated, quality conscious, patient focused manner. Neuroscience 
research, technology, and health service delivery models will continue to evolve, making a 
commitment to lifelong learning and quality improvement particularly important. 
Conclusion: end of the beginning, or beginning of the end? 
As is evident from this Commission, psychiatry as a speciality faces major changes and challenges 
ahead. A revolution is on the way—and psychiatrists need to take hold of the flag and lead from the 
front. 
Psychiatrists need to work with key stakeholders including policy makers and patients to help to 
plan, deliver, and ensure that no matter where in the world their patients live, they get the best 
services possible within the constraints of resources. Mental health professionals need to be well 
trained in integration of biological, psychological, social, and spiritual factors in the care that they 
provide. The contract between psychiatry and society needs to be renegotiated on a regular basis, so 
that clinicians and policy makers are truly representative of society, and are aware of the needs of 
patients and the strengths of the profession. Responsibilities and expectations lie on each side: both 
psychiatrists and the public must be fully cognisant of what each party can deliver. The ultimate aim 
is to provide services that are emotionally accessible, no stigmatising, and meet the needs of some 
of the most vulnerable individuals in society. 
At present, this contract is implicit and not explicit. It has to be made transparent, and based on 
ŵutual eǆpeĐtatioŶs aŶd psǇĐhiatƌǇ͛s ƌole, ƌesponsibilities, and relationships not only with society as 
a whole, but also with stakeholders who include policy makers, other health-care and social care 
professionals, health service managers, service users, carers and families, the media, and politicians. 
This approach is needed to develop advocacy and support so that mental health services and mental 
health research receive the resources they need. Psychiatrists as physicians must primarily 
demonstrate the specific benefits they can bring to wider society and individual service users; at the 
same time, stakeholders in society, such as the state, other health professionals, service users, and 
the media, need to acknowledge their responsibility to support psychiatry and enable it to do its job 
effectively. 
Psychiatrists are not only clinicians, but also members of the society in which they live and work. 
They therefore have dual roles as advocates for all patients in general, and for psychiatric patients in 
particular. Improved coordination and integration of care will benefit not only patients but society as 
a whole. Psychiatrists have to take on board the public mental health agenda with a greater 
consistency as part of a new professionalism. The challenges for psychiatry include resource 
pressures, as well as stigma and mistrust against patients, the subject, and the profession, which 
often seems to be marginalised, deprofessionalised, and undervalued. Therefore, educating 
psychiatrists, the public, and other stakeholders to develop and share examples of good practice is 
an important step. To achieve all of this, clinical leadership by psychiatrists is a must. With patients 
and health professionals, psychiatrists need to advocate for patients and the profession, being open 
aŶd hoŶest aďout the field͛s stƌeŶgths and weaknesses. 
Society, meanwhile, needs to acknowledge and meet the needs of psychiatric patients. Furthermore, 
social determinants of mental illness and the role of social discrimination in the causation of mental 
illness deserve study, but adequate financial resources need to be committed to carry out this 
research. Both advocacy against poverty and unemployment and equitable funding into 
neurosciences and social research is needed. Psychiatrists need to be skilled, competent, 
professional, and collaborative. 
This World Psychiatric Association and Lancet Psychiatry Commission has set the scene for 
psychiatry in the first half of the 21st century. The future cannot be predicted, but it is important to 
remain professional as well as retain professional values that are fit for purpose and be prepared for 
major changes in health care and health-care systems. This is the beginning and not the end—
perhaps it is not even the end of the beginning. 
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